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ABSTRACT 
 
Post-transcriptional regulation of gene expression sits at the core of proteomic 
complexity; trans-acting factors that regulate RNA localization and translation capacity 
are thus indispensible. In this thesis, I present studies of the cytoplasmic 
polyadenylation element binding protein (CPEB), a sequence specific RNA-binding 
protein important for cell cycle progression and neural synaptic plasticity. I focus on 
CPEB because the activity of RNA-binding proteins affects the destiny of their mRNA 
substrates. As presented in Chapter II, CPEB, though mostly cytoplasmic at steady 
state, shuttles between the nucleus and the cytoplasm. Surprisingly, the RNA 
recognition motifs are essential for the nuclear localization. CPEB associates with the 
polyadenylation machinery in both compartments, suggesting it is involved in both 
nuclear mRNA processing and cytoplasmic translational regulation. Moreover, the 
nuclear translocalization is critical to relay a tight translation repression on CPE-
containing mRNAs. Chapter III focuses on the regulation of CPEB dimerization. CPEB 
dimerizes through the RNA-binding domains to inhibit its own RNA binding ability in a 
cell cycle-dependent manner. By dimerizing, CPEB has enhanced binding to protein 
destruction factors so that robust active degradation occurs in the later cell cycle. The 
degradation of CPEB is required for translation activation of a subset of mRNAs and cell 
cycle progression. In addition, dimerization protects cells from being overloaded with 
excess CPEB. In sum, the localization and dimerization status of CPEB is dynamic and 
highly regulated; they in turn regulate the activity of CPEB, which results in responsive 
?translation control. These studies provide a strong foundation to decipher CPEB-
mediated gene expression. 
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CHAPTER I 
 
INTRODUCTION 
 
 
 
Post-transcriptional control 
 Gene expression is a finely regulated process to achieve the proper 
concentration of functional molecules spatially and temporally. Owing to the 
dynamics of the sequence and structures, RNA plays a key role in fine-tuning the 
complexity of gene expression. There are at least two distinct species of RNAs: 
messenger RNAs (mRNAs) and non-coding RNAs, which in sum create a gene 
expression network that is much more sophisticated than the genomic 
information from which they arise. It is intriguing to know that a worm has about 
two thirds of the genes that a human has (2 × 104 versus 3 × 104) and that the 
human and chimpanzee genomic coding regions are 99.7% identical (Calarco et 
al., 2007). Therefore it is reasonable to propose that RNA complexity sits at the 
core of biological complexity. mRNAs encode proteins, the effectors of most 
cellular processes, so the biology of mRNAs and their translational regulation is 
focused in the thesis.  
 
Nuclear mRNA maturation 
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The maturation of functional RNAs is highly regulated, requiring numerous 
regulatory proteins. When the eukaryotic pre-mRNA is transcribed in the nucleus, 
it is spliced, polyadenylated and then exported to the cytoplasm. The mRNA 
processing machinery, such as the scaffold protein symplekin, cleavage and 
polyadenylation factor complex (CPSF) and also the export factors, are recruited 
to the ribonucleoprotein (RNP) co-transcriptionally, and some of the factors also 
function in transcription (Bentley, 2002).  
mRNA splicing and polyadenylation introduce more layers of genetic 
regulation and generate proteomic diversity. Utilizing different splice sites and 
polyadenylation sites allows the generation of multiple mRNAs that possess 
distinct coding and/or regulatory sequences from a single gene. In human cells, it 
is estimated that 95% of multi-exon genes are alternatively spliced, mostly in a 
tissue-specific manner (Wang et al., 2008). In the nucleus, splicing factor 1 (SF1) 
of the spliceosome recognizes the branch point, and the 5’ splice site (GU) is 
recognized by U1 small nuclear ribonucleoprotein (snRNP). U2 auxiliary factor 
(U2AF) then recognizes the 3’ splice site (AG) and its upstream CU-rich 
sequence to form the E complex. The splicing complex then is converted from 
ATP-independent to ATP-dependent pre-spliceosomal A complex after SF1 is 
replaced by U2 snRNP at the branch point. Following this, U4/U6-U5 tri-snRNP 
complex is recruited and leads to the formation of B complex, which contains all 
the spliceosomal subunits. The rearrangement and remodeling of snRNPs allows 
5’ splice site cleavage and lariat formation. In the last step, the lariat is excised 
and the two exons are joined (Chen and Manley, 2009). 
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Alternative splicing is critical for introducing variable exon usage, which 
can result in variable protein structure, location and activity. By changing the 
mRNA exonal structure or the reading frame, it can also affect the half life of the 
mRNA, as suggested by alternative splicing-coupled nonsense-mediated mRNA 
decay (AS-NMD) model (McGlincy and Smith, 2008). The decision as to which 
exons are chosen to generate mature mRNAs is imparted by RNA sequence 
elements and protein regulators. RNA-binding proteins that get access to the pre-
mRNAs can affect the splicing pattern by competing for the splice site and/or the 
recognition sequence with the spliceosome. For example, the neuronal RNA-
binding neuro-oncological ventral antigen (NOVA) proteins, NOVA1 and NOVA2, 
regulate alternative splicing of a subset of mRNAs in the brain to shape synapses. 
NOVA proteins inhibit exon inclusion by competing for the binding of U1 snRNP 
at the 3’ end of an alternative exon (Darnell, 2006). Another very interesting 
example is that polypyrimidine tract-binding proteins (PTB) post-transcriptionally 
suppress expression of their neuronal paralog (nPTB) so that their expression is 
mutually exclusive. Thus, they regulate alternative splicing in completely different 
sets of cells, switching on different splicing programs to shape neuronal 
development (Boutz et al., 2007). Additionally, the activity of RNA-binding 
proteins can be regulated in response to cellular or metabolic stress through 
post-transcriptional modifications, such as phosphorylation, and therefore 
mediate alternative splicing programs (Feng et al., 2008). These reports suggest 
that regulation by RNA-binding proteins allows differential control of splicing in 
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different cell types, developmental status and also a cell’s response to 
environmental stimuli.  
Nearly all eukaryotic pre-mRNAs, with the exception of histone replication-
dependent transcripts, acquire a nontemplated poly(A) tail at their 3’ ends. The 
nuclear polyadenylation factors are recruited co-transcriptionally, recognize the 
polyadenylation site and mark the end of the mRNA with a stretch of adenosine 
residues. Polyadenylation at the 3’ end plays a critical role in gene expression 
because it promotes mRNA release from its site of transcription (Saguez et al., 
2005), and it is indispensible for efficient mRNA export to the cytoplasm where 
mRNA translation takes place (Millevoi and Vagner, 2010). The CPSF complex 
reads the hexanucleotide (HEX, usually AAUAAA or AUUAAA) 10 to 30 
nucleotides (nt) upstream to the actual cleavage site and the multisubunit 
cleavage stimulation factor (CstF) binds to a U/GU track 14 to 70 nt downstream 
to the hexanucleotide to direct polyadenylation. The 73 kD subunit of CPSF 
carries out the cleavage and a poly(A) polymerase elongates the poly(A) tail 
(Lutz, 2008).  
There can be multiple sites for polyadenylation on a single message. In 
the human genome, at least half of the genes are alternatively polyadenylated 
(Iseli et al., 2002). The site of usage depends on the relative ratio of the 
polyadenylation factor CstF to the RNA-binding proteins that compete for the 
same polyadenylation sites (Castelo-Branco et al., 2004) or the auxiliary 
regulatory elements (Phillips et al., 2004), determining which site is accessible to 
the polyadenylation and cleavage machinery. Furthermore, alternative poly(A) 
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site regulation can determine the length of pre-mRNA to be spliced, and thus 
affects the inclusion of alternative exons (Licatalosi and Darnell, 2010). The 
difference of polyadenylation site usage can not only affect the protein coding 
region, but also the content of the 3’ untranslated region (UTR), which provides 
for potential regulation by RNA-binding proteins and microRNAs (miRNAs) for 
mRNA localization, translation and stability. It has been reported that fast 
proliferating cells, including activated T lymphocytes and cancer cells, express 
substantial amounts of mRNA isoforms with shorter 3′ UTRs due to selective 
usage of upstream poly(A) sites. It results in significant loss of repressive 
elements and more protein production that favors (aberrant) proliferation (Mayr 
and Bartel, 2009; Sandberg et al., 2008). As opposed to proliferating cells, non-
proliferating tissues, such as the brain, harbors mRNAs with longer 3’-UTRs to 
allow for more comprehensive regulation (Licatalosi et al., 2008). To summarize, 
alternative splicing and alternative polyadenylation are important regulation 
points of gene expression because they can affect not only the protein coding 
sequence but also regulatory elements required for localization, stability and 
translation. These processes depend on cis elements encoded in the genomic 
sequence and trans RNA-binding proteins that recognize them and further recruit 
various sets of catalytic factors through protein-protein interactions. Nuclear 
RNA-binding proteins are thus critical to integrate the post-transcriptional 
processing steps. Moreover, as presented in this thesis, many RNA-binding 
proteins shuttle between the nucleus and the cytoplasm to convey signals to 
nuclear RNA processing and/or to cytoplasmic post-transcriptional regulation. 
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Cytoplasmic translational control 
Matured mRNAs exported from the nucleus are subject to control to 
ensure a proper protein expression pattern. This is achieved by mRNA 
localization, translation control and regulated degradation. Localized translation 
is especially relevant in transcriptionally silenced germ line cells and highly 
polarized cells, including differentiated neurons, because the site of transcription 
can be far removed from the final location of the protein. Moreover, translation of 
localized mRNA in response to extracellular stimulation allows for greater spatial 
and temporal resolution, ensuring a fast and efficient way to adjust to novel 
environmental conditions. 
In Drosophila embryos, more than 70% of the transcripts are found in 
spatially distinct patterns, suggesting that mRNA localization is a widespread 
phenomenon crucial for germ line differentiation and development (Lecuyer et al., 
2007). The translation regulators that repress translation during transport and 
activate translation of the localized mRNA in response to cellular cues are 
asymmetrically present and recruited to the mRNA by cis binding elements 
encoded in the 3’-UTR. The trans binding factors thus together determine the 
localization and the translation status to give rise to a specific expression map of 
each transcript. 
Two major cytoplasmic regulators of protein expression are RNA-binding 
proteins and miRNAs. RNA-binding proteins are proteins harboring one or more 
RNA-binding domains, such as the RNA Recognition Motif (RRM, also known as 
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RBD or RNP domain), K Homology (KH) domain, Zinc finger (ZF), RGG box, 
DEAD/DEAH box, Pumilio/FBF (PUF) domain, double-stranded RNA binding 
domain (ds-RBD), Piwi/Argonaute/Zwille (PAZ) domain, Sm domain, etc. 
miRNAs are endogenous short RNAs (average 23 nt) that partially basepair with 
target mRNAs, usually leading to translational repression, target degradation and 
gene silencing (Bartel, 2004). The interplay between these two players may 
determine the dynamics of mRNA translation. For example, HuR, an AU-rich-
element binding protein, can bind to the 3’ UTR of cationic amino acid transporter 
1 mRNA and relieve the mRNA from miR-122-induced inhibition in human 
hepatocarcinoma cells subjected to different stress conditions, suggesting that 
proteins interacting with the 3′-UTR generally act as modifiers altering the 
potential of miRNAs to repress gene expression (Bhattacharyya et al., 2006). 
The rate limiting step of translation is initiation, which is where regulation 
most commonly occurs. Eukaryotic translation initiation usually involves a 5’-cap 
structure – m7GpppN, which attracts the eukaryotic initiation factor (eIF) 4E, the 
cap-binding protein. eIF4E, eIF4A, the ATP-dependent RNA helicase that aids 
the initiation complex in resolving certain secondary structures formed by the 
mRNA transcript, and the scaffolding factor eIF4G together comprise the eIF4F 
complex. eIF4G directly binds to eIF3, a multisubunit factor in the 43S complex, 
which is composed of a small 40S ribosomal subunit, the ternary complex of eIF2 
with GTP and Met-tRNAi and eIF3. The 43S pre-initiation complex that 
assembles at the cap scans through the mRNA to search for the first AUG start 
codon. Positioning of the pre-initiation complex at the start codon triggers eIF2-
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bound GTP hydrolysis, which signals for the dissociation of several initiation 
factors from the small ribosomal subunit and the association of the ribosomal 
large subunit 60S. The complete ribosome (80S) then commences translation 
elongation until the recognition of a stop codon that brings in translation 
termination factors to terminate peptide synthesis (Preiss and Hentze, 1999). 
Translation can be regulated by the accessibility of the translational 
machinery to the mRNA 5’- and 3’-ends. Polyadenylation favors the 
circularization of mRNPs, and 5’-cap binding proteins and eIF4E-binding proteins 
can influence the incorporation of the initiation complex and control initiation. The 
latter is exemplified by the eIF4E-binding protein 4E-BP1. Nonphosphorylated 
4E-BP1 binds eIF4E and inhibits it from interacting with eIF4G and thus blocks 
translation initiation. Hyperphosphorylated 4E-BP1 dissociates from eIF4E, 
resulting in increased cellular translation (Lasko, 2003), which makes 4E-BP1 
phosphorylation a key modification target in the cells encountering hormonal 
stimulation, stress, or pathological challenges. A long poly(A) tail, 80 to 250 nt, is 
thought to stimulate translation via the interaction of poly(A)-binding protein 
(PABP) with the cap-binding complex, which promotes the formation of a cap-to-
tail closed loop that confers translational efficiency to the mRNA (Tarun et al., 
1997). Cytoplasmic polyadenylation is regulated independently of nuclear 
polyadenylation. After the message is transported into the cytoplasm, another set 
of polyadenylation factors partially replaces the nuclear polyadenylation factors. 
In the cytoplasm, the poly(A) tail protects mRNA from hydrolysis by 
exonucleases and enhances translation efficiency. The poly(A) tail is dynamic; it 
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is controlled by the activity of a cytoplasmic poly(A) polymerase and a 
deadenylase, and hence under the regulation of RNA-binding proteins that recruit 
these enzymes to the messages. The best characterized mechanism of 
cytoplasmic polyadenylation is CPEB (cytoplasmic polyadenylation element-
binding protein)-mediated polyadenylation. 
  
CPEB translational control 
3’-UTRs of mRNAs often associate with RNA-binding proteins, which in 
turn determine the fate of the mRNA. The recognition of mRNA by these proteins 
can be sequence-independent or sequence specific. CPEB was first identified in 
Xenopus oocytes as a sequence-specific RNA binding protein that recognizes a 
U-rich sequence (U4-6A1-3U1-2). There are two RRMs (RRM1 and RRM2) and two 
ZFs in the C terminus of CPEB. RRM1 determines the sequence specificity 
(Huang et al., 2006), but all four motifs are essential for RNA binding. Deletion of 
RRM1 and the ZFs results in undetectable binding, while deletion of RRM2 
results in 15% of RNA binding ability compared to the full-length CPEB (Hake et 
al., 1998). The N-terminal half of CPEB contains domains for protein-protein 
interactions, including binding sites for tubulin, the protein that guides CPEB to 
the mitotic spindle (Groisman et al., 2000), transmembrane amyloid precursor-
like protein 1 (APLP1) that brings CPEB to the membrane and stimulates CPEB 
activation (Cao et al., 2005), and Rho-family guanine nucleotide exchange factor 
xGEF that is required for CPEB activation in the mitogen-activated protein kinase 
(MAPK) pathway (Reverte et al., 2003). The N terminal half of the protein also 
10 
 
has phosphorylation sites that alter CPEB activation status (see below). Thus, 
CPEB identifies mRNA substrates using its C terminus and can recruit other 
protein factors through the N terminus to regulate the translation. However, as 
presented in Chapter III of this thesis, RNA binding domains are sometimes used 
for protein-protein interactions as well (Clery et al., 2008); therefore, the protein 
interaction region of CPEB is not restricted to the N terminus. 
CPEB acts as a translational switch to repress translation in the dormant 
state and to activate translation in response to stimuli. The molecular mechanism 
is best studied in the Xenopus oocyte. Immature oocytes are arrested in the first 
meiotic prophase. Before they can be fertilized, they must re-enter progesterone-
driven meiotic divisions (oocyte maturation), where transcription is mostly silent. 
The stimulated oocytes undergo germinal vesicle break down (GVBD) in the first 
meiosis, which is visible as a white spot on the animal pole, and again arrest at 
metaphase II, awaiting fertilization before they can complete the final meiotic 
division and initiate embryonic cell divisions. A signaling cascade beginning with 
Mos, a serine/threonine kinase, plays a key role in oocyte maturation. Mos 
induces the MAPK cascade that activates cyclin B/ cyclin-dependent kinase 1 
(Cdk1), a heterodimer also known as M-phase promoting factor (MPF). This 
activation requires newly synthesized cyclin B1 protein to be assembled into a 
small amount of active MPF, which induces an auto-amplification loop by 
activating stored pre-MPF, subsequently promoting the meiotic progression 
(Mendez and Richter, 2001). However, transcription is mostly inactive in oocytes 
and those proteins are not translated until hormone stimulation; therefore, the 
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timely translation of maternal mRNA is required to support cell cycle progression 
and oocyte maturation.  
In the dormant oocyte, the CPEB RNP contains a scaffold protein 
Symplekin, polyadenylate polymerase Gld2 (germ line defective 2) (Barnard et al., 
2004) and poly(A)-specific ribonuclease (PARN). The activities of Gld2 and 
PARN antagonize each other and keep the poly(A) tail short (about 20 to 40 
adenosines); therefore, translation is silent (Kim and Richter, 2006). When the 
cell is stimulated by hormones (progesterone or insulin), Aurora A kinase 
activated by glycogen synthase kinase 3 (GSK3), and/or MAPK phosphorylates 
CPEB at S174 site (Keady et al., 2007; Mendez et al., 2000a; Sarkissian et al., 
2004). The phosphorylation decreases its affinity for PARN and increases its 
affinity for CPSF complex, a nuclear and cytoplasmic polyadenylation complex, 
which results in mRNA polyadenylation and translation activation (Kim and 
Richter, 2006; Mendez et al., 2000b). In sum, the phosphorylation status of 
CPEB, which is cell cycle-regulated, alters the binding partners of CPEB and 
consequently silences or activates mRNAs essential for cell cycle progression 
(Fig. 1-1). 
CPEB not only regulates translation through 3’ polyadenylation, it also 
affects translation initiation from the 5’ end through eIF4E binding proteins, 
among which are Maskin, Neuroguidin and 4E-transporter (4E-T). Maskin was 
identified as a CPEB-binding protein by CPEB-pull down experiments using 
Xenopus oocyte extracts. It is expressed in oocytes and early embryos 
(Stebbins-Boaz et al., 1999). Maskin also binds to eIF4E and can thus inhibit 
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eIF4G from joining the cap to repress translation in a CPE-dependent manner. 
The activity of Maskin is cell-cycle regulated by phosphorylation. Residue S626 is 
phosphorylated by protein kinase A (PKA) (Barnard et al., 2005) or Aurora A 
(Pascreau et al., 2005) to direct Maskin to mitotic spindles for local translational 
control. Further, multiple phosphorylations by Cdk1 help dissociate Maskin from 
the cap complex to relieve translation inhibition in maturing oocytes (Barnard et 
al., 2005). The phosphatase Calcineurin comes in later to dephosphorylate 
Maskin and restore its binding to eIF4E; therefore, the translation repression of 
Maskin oscillates during the cell cycle (Cao et al., 2006). Maskin is replaced by 
Neuroguidin in later embryonic development (also in the mammalian nervous 
system) to exert CPE-mediated translation repression (Jung et al., 2006). 
Another eIF4E-binding protein co-immunoprecipitated with CPEB is 4E-T. It 
associates with eIF4E1b, an isoform of eIF4E that is restricted to oocytes and 
early embryogenesis. eIF4E1b is an atypical cap-binding protein, with stronger 
affinity to 4E-T than to eIF4G, which may explain its inhibitory effect on 
translation (Minshall et al., 2007). In addition, CPEB-mediated polyadenylation 
releases embryonic PABP (ePAB) from the CPEB repression complex so that it 
can bind the newly elongated tail (Kim and Richter, 2007). ePAB reinforces 
mRNP circularization through the interaction with eIF4G, which can help release 
those 4E-binding proteins from the cap complex, allowing eIF4G interaction with 
eIF4E and translation initiation (Cao and Richter, 2002). In these ways, CPEB 
mediates translation by regulation of cytoplasmic polyadenylation and dynamic 
interactions with eIF4E-binding proteins.  
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As a maturing oocyte progresses into meiosis, CPEB is subjected to intensive 
degradation, which coincides with Cdk1 hyperphosphorylation. Expression of 
CPEB bearing Cdk1 phosphorylation mutations blocks entry into metaphase II 
from metaphase I of oocyte maturation (Mendez et al., 2002). A phosphorylation 
site of Cdk1 in CPEB, Thr125, is recognized by Polo-like kinase (Plx1), which 
phosphorylates the TSG motif in the PEST domain (a Pro/Glu/Ser/Thr-rich 
sequence), which then becomes the targeting site of the F-box protein β-TrCP 
(β-transducing repeat-containing protein) of the E3-ligase complex SCF β-TrCP 
(Skp1-Cullin-F-box protein complex that contains β-TrCP) (Setoyama et al., 
2007). These interactions ensure a timely turnover of CPEB protein in the mature 
oocyte. The importance of CPEB degradation is further demonstrated by a 
systematic study of a CPE combinatorial code showing that there are two waves 
of CPE-mediated translation activation; early activation requires a CPE within 
100 nt to HEX, with the optimal distance of 25 nt, and late activation requires at 
least two CPEs, one of which overlaps with HEX (Pique et al., 2008). It implies 
that for late activation, the CPE overlapping with HEX has to be freed for CPSF 
binding, possibly due to the partial degradation of hyperphosphorylated CPEB 
(Fig. 1-2). 
It is noteworthy that CPEB also functions coordinately with other RNA-
binding proteins, among which pumilio is the most evident. Pumilio belongs to a 
highly conserved family of RNA binding proteins called the Puf family that 
mediates translational repression and mRNA destabilization. Pumilio can directly 
interact with CPEB (Nakahata et al., 2001) or get recruited to the binding sites of 
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CPE-containing mRNAs (Pique et al., 2008). Thus, their interactions could be 
both protein-RNA and protein-protein mediated. Association with pumilio can 
direct mRNA to deadenylation (Nakahata et al., 2003); interactions (either 
synergy or competition) with other RNA-binding proteins can further expand the 
CPEB-regulation network. 
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Figure 1-1. CPEB acts as a translational switch. The nonphosphorylated form of 
CPEB associates with both deadenylase PARN and poly(A) polymerase Gld2, 
whose activities antagonize each other and to keep the poly(A) tail short. CPEB 
is phosphorylated by Aurora A kinase, which is activated in a cell cycle-
dependent manner. Once CPEB is phosphorylated, PARN is expelled from the 
complex, and thus the activity of Gld2 dominates and elongates the tail. At the 
same time, ePAB in the CPEB complex is released to the tail; this protects the 
tail from degradation and reinforces the circularization of mRNA through the 
interaction with eIF4G to facilitate translation. Note that the phosphorylation 
status of Maskin, a CPEB and eIF4E-binding protein, is also regulated in a cell 
cycle-dependent manner. The hyperphosphorylation of Maskin helps its 
dissociation from eIF4E to allow eIF4G joining. Thus, the CPEB complex 
regulates translation by controlling polyadenylation at the 3’ end and assembly of 
initiation complex at the 5’ cap. 
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Figure 1-2. Sequential translation activation by the combinatorial CPE codes. 
During oocyte maturation, CPEB is phosphorylated by Aurora A kinase and 
switches from a translational repressor to a translational activator, and later part 
of CPEB is subject to degradation mediated by Cdk1 hyperphosphorylation. It 
requires two CPEs for translation repression in dormant oocytes. mRNAs with 
separated CPE and polyadenylation signal (HEX) become translationally 
activated once CPEB is phosphorylated by Aurora A (left panel); whereas 
mRNAs with the HEX overlapping with a CPE are not activated until CPEB 
undergoes degradation (right panel). Thus, through different arrangement of 
CPEs and the HEX element, CPEB mediates translational activation in a 
temporal order. 
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Figure 1-2 
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CPEB functions in cell cycle regulation 
CPEB was first identified as a key regulator of oocyte development and 
spermatogenesis. Studies of Xenopus oocytes show that activation of CPEB and 
the consequent translation of mos, Cdk2 and cyclin A1, B1, B2 mRNA are 
essential for meiotic cell cycle progression (Mendez et al., 2000a; Stebbins-Boaz 
et al., 1996). The same mechanism of translation of cyclin B1 following Aurora A 
activation of CPEB was also reported in the mouse oocyte (Hodgman et al., 2001; 
Tay et al., 2000). Furthermore, studies from the CPEB (also called CPEB1 to 
distinguish from other CPEB family members) knockout (KO) mouse 
demonstrate that CPEB is essential for both oocyte and sperm development 
since the female CPEB KO mice have no detectable ovaries and the testis in the 
male KO mouse is 30% smaller than the wild type (WT). Due to the defective 
CPEB-dependent translation of synaptonemal complex proteins, the KO germ 
cells are arrested in the pachytene stage and undergo apoptosis (Tay and 
Richter, 2001). The study of Aurora A-dependent phosphorylation of CPEB also 
shows intensive phosphorylation on E16.5, when most oocytes are in the 
pachytene stage, and not at E14.5 or E18.5, suggesting a fine-tuned temporal 
control of CPEB-mediated translation activation (Tay et al., 2003). However, 
CPEB not only affects oocyte development up to pachytene stage, transgenic 
mice that turn on small interfering RNA against CPEB after pachytene stage still 
show abnormality of the oocytes, including parthenogenetic cell division in the 
ovary and various morphological abnormalities of the oocytes and the polar 
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bodies, indicating that CPEB functions in both early and late meiotic development 
of the mouse germ cells (Racki and Richter, 2006). 
More recent studies show that CPEB regulates translation in the mitotic cell 
cycle as in the meiotic cell cycle. In Xenopus embryos, CPEB-dependent 
polyadenylation and translation control of cyclin B1 mRNA mediates mitotic cell 
cycle progression (Groisman et al., 2002). In addition, in the NIH3T3 cell line, of 
which the transcription is not absent as in oocytes and early embryos, CPEB also 
plays a role in the cycle-dependent polyadenylation and translation control 
(Novoa et al., 2010), suggesting that CPEB-mediated translation is a general 
mechanism to control meiosis and mitosis. 
In addition to cellular translational control, CPEB is also involved in spindle-
localized translation. In the Xenopus oocyte, CPEB, Maskin, Aurora A kinase, 
CPSF and CPE-containing mRNAs, such as bub3 and cyclin B1 mRNA, all 
localize on the mitotic spindle (Groisman et al., 2000). A more detailed study 
shows that the spindle localization of mRNA is indeed CPE-dependent and is 
required for its protein accumulation, which in turn is critical for the metaphase I 
to metaphase II transition (Eliscovich et al., 2008). 
Considering the involvement of CPEB in cell cycle regulation, it is surprising 
that the CPEB KO mouse is not only viable but has a normal life span, and that 
its primary cells appear to divide normally. However, more detailed studies 
unveiled the involvement of CPEB in regulating cellular senescence. Cellular 
senescence is a stress-induced cell cycle arrest that limits proliferation of mitotic 
cells, and is considered as a tumor suppression program (Serrano et al., 1997). 
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CPEB KO mouse embryonic fibroblasts (MEFs) bypass senescence, possibly 
through increased translation of myc mRNA (Groisman et al., 2006). Furthermore, 
in human primary foreskin fibroblasts, CPEB is also found to be essential to 
initiate cellular senescence through the p53 pathway (Burns and Richter, 2008). 
These data, together with the finding from human patients that CPEB mRNA is 
downregulated 17 fold in ovarian cancer (Hansen et al., 2009) suggest that 
CPEB is critical for senescence and may act as a tumor suppressor. 
 
CPEB functions in the nervous system 
Translational regulation is critical for distal cellular compartments that are 
beyond the timely regulation of the nuclear transcription. It is applied to local 
translation in neurites (axons and dendrites) to react promptly and independently 
to the extracellular stimulation. The translational machinery and mRNAs have 
been shown to localize to synapto-dendritic regions (Steward and Schuman, 
2001), apparently endowing individual synapses with the capacity of local protein 
synthesis. CPEB is enriched in the brain (Wu et al., 1998; Theis et al., 2003) and 
localized to synapses together with polyadenylation factors (Huang et al., 2002). 
Moreover, CPEB regulates dendritic mRNA localization (Huang et al., 2003; Oe 
and Yoneda, 2010) and synaptic polyadenylation and translation upon N-methyl-
D-aspartate (NMDA) stimulation (Huang et al., 2002; Wells et al., 2001). The 
CPEB KO mouse displays deficits in long-term potentiation (LTP) -- persistent 
increase in synaptic strength -- evoked by theta-burst stimulation (Alarcon et al., 
2004), and reduced extinction as assessed by a swim-maze task and during 
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contextual fear conditioning, two hippocampal–dependent memory tasks (Berger-
Sweeney et al., 2006). Furthermore, transgenic mice that express CPEB bearing 
Aurora A phosphorylation site mutations (T171A and S177A) in cerebellar 
Purkinje neurons show loss of protein synthesis-dependent phase of parallel 
fiber-Purkinje neuron long term depression and a change in spine morphology 
(McEvoy et al., 2007). It seems that CPEB also regulates the local translation of 
β-catenin, a protein localized to the leading edge of migrating astrocytes (Jones 
et al., 2008). In addition, a proteomic screen discovered that CPEB controls 
growth hormone expression via regulation of translation of the transcriptional 
factor c-jun; this complex regulation may underline the LTP deficits of the KO 
mice (Zearfoss et al., 2008). In Xenopus, CPEB also affects experience-
dependent neuronal development and circuit formation in the visual system 
(Bestman and Cline, 2008). Finally, Aplysia CPEB is also involved in mRNA 
transport and contributes to long-term facilitation of the sensory neurons in 
response to neurotransmitter stimulation (Liu et al., 2006; Miniaci et al., 2008; Si 
et al., 2010). Taken together, these observations indicate that CPEB plays an 
important role in regulating neuronal mRNA transport and local translation to 
control synaptic plasticity and learning and memory. 
 
CPEB family of proteins 
Studies and comparisons of CPEB homologues among species provide a 
more complete picture of CPEB functions. In C. elegans, CPEB homologues Cpb 
(CPEB polyA binding family)-1 and Fog (feminization of the germ line)-1 have 
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key functions in spermatogenesis. Cpb-1 is essential for progression through 
meiosis, and Fog-1 is required for specification of the sperm fate (Jin et al., 
2001b; Luitjens et al., 2000). The low abundance of FOG-1 in proliferating germ 
cells promotes mitosis, while the high abundance in the terminal germ cells 
directs the cells into spermatogenesis (Thompson et al., 2005). Another CPEB 
homolog Cpb-3 regulates meiotic progression of oogenesis (Hasegawa et al., 
2006). 
The Drosophila CPEB homologue is Orb (oo18 RNA-binding protein). It 
regulates the localization and translation of gurken and oskar mRNAs, which 
establish embryonic dorso-ventral and the antero-posterior axes, respectively 
(Castagnetti and Ephrussi, 2003; Chang et al., 1999; Chang et al., 2001). 
Intriguingly, ORB is required to localize its own mRNA and hence the in situ 
accumulation of ORB protein (Tan et al., 2001), forming a positive feedback loop 
to ensure the protein’s accumulation for downstream translation regulation and 
axis formation. Additionally, autoregulation is also reported for C. elegans FOG-1 
protein and fog-1 transcript (Jin et al., 2001a). There are also multiple CPE-like 
sequences in Xenopus and mammalian CPEB 3’ UTRs, but an autoregulation 
loop has not been reported. From the studies of C. elegans, Drosophila, Xenopus 
and mouse CPEB presented above and similar findings in clam (Minshall et al., 
1999), zebrafish (Bally-Cuif et al., 1998) and porcine CPEB (Nishimura et al., 
2010), CPEB is conserved in translation regulation in the germ line. 
In vertebrates, there are four members in the CPEB family, namely 
CPEB(1), CPEB2, CPEB3 and CPEB4. Although they are highly conserved in 
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the C terminal RNA-binding domain (~45% homology from CPEB1 to 
CPEB2/3/4), CPEB2, 3 and 4 are mapped more closely on the phylogenic tree, 
with about 98% to 99% of homology in their RNA-binding domains (Theis et al., 
2003). They are reported to bind a U-rich stem-loop RNA structure that is distinct 
from CPEs (Huang et al., 2006), though this doesn’t exclude their potential to 
bind a stem-loop structure that contains CPEs; for example, CPEs of mouse 
cyclin B1 seem to be bound by both CPEB1 and CPEB4 (Igea and Mendez, 
2010). From the sequence homology, CPEB(1) is of the same subgroup of 
Drosophila Orb, while CPEB2/3/4 are of that of Orb2. In adult flies, ORB2 
expresses mainly in the brain and ventral ganglia and is enriched in the 
mushroom body. It has been implicated in courtship behavior-related long-term 
memory (Keleman et al., 2007). Other evidence of Orb2’s involvement in neural 
function come from a study using a candidate gene approach combined with a 
genome-wide screen showing that Orb2 regulates genes of neural growth, 
synaptic function and protein turnover (Mastushita-Sakai et al., 2010). 
 Similar to Drosophila Orb2, mammalian CPEB2/3/4 also function in neural 
systems, though CPEB2 was first identified in mouse round spermatids, 
suggesting a possible role in translational regulation of spermatogenesis 
(Kurihara et al., 2003). The expression of CPEB2/3/4 concentrates in the brain, 
especially in the hippocampus, and can be induced by the injection of kainate, a 
glutamate receptor agonist that leads to strong neuronal activation and seizures 
(Theis et al., 2003). CPEB2/3/4 do not have the Aurora A phosphorylation site as 
CPEB(1), and their N terminal regulatory domain is only loosely conserved with 
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CPEB(1); therefore, they might function with different signaling pathways. CPEB3 
has been shown to recruit the deadenylase CAF1 through interaction with an 
anti-proliferative protein TOB (Hosoda et al., 2011). Recently, CPEB2 has been 
shown to associate with elongation factor eEF2 and decrease eEF2/ribosome-
triggered GTP hydrolysis and thus reduce peptide elongation of CPEB2-bound 
mRNAs (Chen and Huang, 2011).  
CPEB2/3/4 are all nucleus-cytoplasm shuttling proteins as CPEB(1) (see 
Chapter II). In neurons, CPEB3 is shown to associate with a transcriptional factor 
STAT5b and negatively regulate its transcription activity in the nucleus (Peng et 
al., 2010). CPEB4 is reported as a cell survival protein that is retained in the 
nucleus when cells experience ischemia or endoplasmic reticulum calcium 
depletion (Kan et al., 2010). Interestingly, an intron region of cpeb3 possesses a 
human hepatitis delta virus (HDV)-like ribozyme (Salehi-Ashtiani et al., 2006), 
and a single nucleotide polymorphism in this region can enhance the self-
cleavage of cpeb3 pre-mRNA. Consequently, less CPEB3 protein accumulates 
and this leads to decreased episodic memory performance (Vogler et al., 2009). 
Based on the evidence above, CPEB2/3/4 seem to have conserved functions in 
the nervous system; however, their regulation may be largely diverged. 
 The CPEB family proteins can also interplay with each other. CPEB2, 3 
and 4 possess overlapping miRNA binding sites and are regulated by the same 
miRNAs (Morgan et al., 2010). By titrating out the cellular miRNA, CPEB2, 3 and 
4 expression levels may also affect the translation of other CPEB members. 
Moreover, the polyadenylation and translation of cpeb4 mRNA has been reported 
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to be positively regulated by CPEB(1) through the CPEs in the 3’ UTR (Igea and 
Mendez, 2010). In addition, there are many isoforms of each CPEB, of which the 
expression pattern is distinctive (Theis et al., 2003; Wang and Cooper, 2009; 
Wang and Cooper, 2010), adding up the complexity of CPEB regulation and 
biological function. 
 CPEB has critical and conserved functions of translational control in germ 
line and somatic cells. It therefore becomes important to understand how CPEB 
itself is regulated. My focus of the thesis is to study the biochemistry of CPEB 
protein and the regulation of the localization and the activation status of CPEB, 
hopefully to provide a better foundation as to decipher the CPEB-mediated 
translational control. 
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Abstract 
 
CPEB is a sequence-specific RNA binding protein that promotes 
polyadenylation-induced translation in early development, during cell cycle 
progression and cellular senescence, and following neuronal synapse stimulation. 
It controls polyadenylation and translation through other interacting molecules, 
most notably the poly(A) polymerase Gld2, the deadenylating enzyme PARN, 
and the eIF4E-binding protein Maskin. Here, we report that CPEB shuttles 
between the nucleus and cytoplasm and that its export occurs via the CRM1-
dependent pathway. In the nucleus of Xenopus oocytes, CPEB associates with 
lampbrush chromosomes and several proteins involved in nuclear RNA 
processing. CPEB also interacts with Maskin in the nucleus as well as with CPE-
containing mRNAs. Although the CPE does not regulate mRNA export, it 
influences the degree to which mRNAs are translationally repressed in the 
cytoplasm. Moreover, CPEB directly or indirectly mediates the alternative splicing 
of at least one pre-mRNA in mouse embryo fibroblasts as well as certain mouse 
tissues. We propose that CPEB, together with Maskin, binds mRNA in the 
nucleus to ensure tight translational repression upon export to the cytoplasm. In 
addition, we propose that nuclear CPEB regulates specific pre-mRNA alternative 
splicing.  
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Introduction 
 
In early embryonic development prior to the onset of robust transcription, 
most protein production is directed predominantly by maternally-inherited mRNAs. 
In Xenopus, these maternal mRNAs are dormant in oocytes arrested at the end 
of prophase, which resembles G2 of the mitotic cell cycle. Upon stimulation of 
oocyte maturation by progesterone, the cells re-enter the meiotic divisions and 
arrest again at metaphase II. During this time, a number of mRNAs that have 
relatively short poly(A) tails (~20-40 nucleotides) undergo poly(A) elongation (to 
~150 nucleotides), which is coincident with translational activation. Two 
regulatory elements in mRNA 3’ untranslated regions (UTR), the cytoplasmic 
polyadenylation element (CPE) and the polyadenylation hexanucleotide AAUAAA, 
are necessary for polyadenylation (Mendez and Richter, 2001). The CPE is 
recognized by the RNA binding protein CPEB (Hake and Richter, 1994) while 
AAUAAA is bound by the multi-subunit complex CPSF (Dickson et al., 1999). In 
oocytes, prior to the onset of polyadenylation, CPEB is associated with both the 
poly(A) polymerase Gld2 (Barnard et al., 2004) and the poly(A)-specific 
ribonuclease PARN. These two enzymes are both active in oocytes, but because 
PARN activity is more robust, the poly(A) tail is kept short (Kim and Richter, 
2006). In addition to these factors, CPEB also interacts with Maskin (Stebbins-
Boaz et al., 1999), a eukaryotic initiation factor (eIF) 4E-binding protein that 
prevents eIF4G from joining the cap binding complex (eIF4F) and thus inhibits 
translation initiation. When the oocytes are stimulated by progesterone, CPEB is 
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phosphorylated on S174 (Mendez et al., 2000a), which in turn causes CPEB to 
strongly associate with CPSF (Mendez et al., 2000b) and expel PARN from the 
polyadenylation complex. Thus, poly(A) tail growth occurs by default, because 
PARN is no longer present to remove Gld2-catalyzed polyadenylation (Kim and 
Richter, 2006). 
Symplekin (Keon et al., 1996; Takagaki and Manley, 2000; Barnard et al., 
2004), which may acts as a scaffold upon which multiple factors are assembled, 
and ePAB, an embryonic-type poly(A) binding protein (Voeltz et al., 2001; Kim 
and Richter, 2007), are two additional proteins in the polyadenylation complex. 
ePAB dissociates from the polyadenylation complex when CPEB undergoes a 
subsequent round of cdk1-catalyzed phosphorylations and binds the newly 
elongated poly(A) tail. Here, ePAB not only protects the tail from degradation, but 
also binds the initiation factor eIF4G; this interaction helps eIF4G displace 
Maskin from and itself bind to eIF4E (Cao and Richter, 2002; Kim and Richter, 
2007), resulting in initiation. Thus, through interactions with multiple proteins, 
CPEB acts as a translational switch during the meiotic divisions. 
 Several studies suggest that cytoplasmic regulation of mRNA begins with 
the association of nuclear-cytoplasmic shuttling factors. For example, nuclear 
binding of hnRNP I to Vg1 mRNA remodels the RNP complex so that 
Vg1RBP/vera can subsequently bind and direct vegetal localization of the mRNA 
in Xenopus oocytes (Kress et al., 2004; Lewis et al., 2008). Moreover, the 
nuclear interaction between the yeast ASH1 mRNA and the She2 protein is 
important for recruiting the translation repressor Puf6p and Loc1p; such factors 
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are responsible for asymmetric translation repression after cytokinesis (Du et al., 
2008; Shen et al., 2009; Gu et al., 2004). These and several other reports (e.g., 
Hachet and Ephrussi, 2004; Shibuya et al., 2004; Huttelmaier et al., 2005; Huynh 
et al., 2004; Yano et al., 2004) suggest that the nuclear history of mRNA can 
affect their cytoplasmic fate, possibly due to factors deposited on the RNAs 
during biogenesis and/or transport. 
 Recently, CPEB has been shown to shuttle between nucleus and 
cytoplasm (Rouget et al., 2006; Ernoult-Lange et al., 2009), although the 
significance of this phenomenon is unclear. We have also found that CPEB 
shuttles between nucleus and cytoplasm, and have investigated the functional 
importance of CPEB in the nucleus. In Xenopus oocytes, nuclear CPEB 
associates with transcriptionally active lampbrush chromosomes in an RNase-
sensitive manner. CPEB co-immunoprecipitation experiments show that it binds 
nuclear CPE-containing RNA as well as several RNA processing factors. In the 
nucleus, Maskin, but not Gld2 or PARN, are components of the CPEB-containing 
RNP complex. Experiments involving the injection of plasmid DNA or RNA into 
the nucleus and RNA into the cytoplasm indicate that the CPE, and by extension 
CPEB and probably Maskin, bind RNA in the nucleus to ensure that it is tightly 
repressed following export to the cytoplasm. Thus, the nuclear experience of 
CPEB helps dictate the cytoplasmic fate of mRNA. In addition, because of this 
CPEB nuclear experience, we also investigated the possibility that it could 
mediate specific alternative exon usage; indeed, CPEB KO mouse embryo 
fibroblasts (MEFs) and tissues derived from CPEB KO mice differentially splice at 
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least one pre-mRNA that encodes collagen 9a1. Thus, CPEB mediates both 
cytoplasmic and nuclear RNA processing. 
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Results 
 
CPEB is a nuclear-cytoplasmic shuttling protein 
In stage VI Xenopus oocytes, CPEB is almost exclusively cytoplasmic 
(Hake and Richter, 1994), although a small amount is nuclear in stage I/II 
oocytes (Fig. 2-1A, the left panel shows the quality of the antibody; the right 
panel shows CPEB during oocyte maturation). However, when oocytes were 
treated with leptomycin B (LMB), which blocks protein nuclear export via the 
CRM1 (Chromosome Region Maintenance 1)-dependent pathway, a substantial 
amount of CPEB was detected in the nucleus (germinal vesicle) (Fig. 2-1B). 
Moreover, while CPEB was cytoplasmic in mouse embryo fibroblasts (MEFs) 
transfected with DNA encoding mouse CPEB fused to the HA epitope, it became 
mostly nuclear when the cells were incubated with LMB (Fig. 2-1C). These 
results, which were also observed in HeLa cells and 293T cells (data not shown), 
suggest that CPEB shuttles between the nucleus and cytoplasm.  
To determine whether CPEB is associated with nascent transcripts in the 
oocyte nucleus, lampbrush chromosomes, structures of intense transcription that 
can readily be detected by light or fluorescence microscopy (Smillie and 
Sommerville, 2002), were prepared. Fig. 2-1D shows that both symplekin and 
CPEB were associated with the lampbrush chromosomes, but that at least in the 
case of CPEB, the association was RNase A-sensitive. These data indicate that 
CPEB interacts with nascent chromosome-associated transcripts in the nucleus. 
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Figure 2-1. CPEB is a nuclear-cytoplasmic shuttling protein. (A) Left: western 
blot of Xenopus oocyte lysate demonstrated the specificity of CPEB antibody 
used in this study. Right: Nuclei and cytoplasms from oocytes of different stages 
were manually separated and probed on western blots for CPEB and tubulin. (B) 
Stage VI oocytes were treated with 200 nM leptomycin B overnight; nuclei and 
cytoplasms were then manually separated and probed for CPEB, tubulin as a 
cytoplasmic marker, and histone H4 as a nuclear marker. (C) MEFs were 
transfected with CPEB-HA, some of which were then treated with 10 nM LMB for 
5 hours. The HA epitope was located by indirect immunofluorescence. (D) 
Lampbrush chromosomes were prepared and immunostained for symplekin and 
CPEB. Some preparations were treated with RNase before immunolocalization 
for CPEB. The chromosomes were also stained with DAPI. 
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Figure 2-1 
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Complex control of CPEB nuclear import 
To identify the regions of CPEB that mediate its nuclear import and export, 
3T3 cells were infected with retroviruses harboring HA-tagged wild type and 
deletion mutant constructs (Fig. 2-2A). Some of the cells were subsequently 
treated with LMB; CPEB was then localized by indirect immunofluorescence for 
the HA epitope (Fig. 2-2B). In the absence of a nuclear localization signal (NLS), 
CPEB would be expected to be cytoplasmic even when cells were incubated in 
the presence of LMB. Indeed, deletion of CPEB residues 206-510 in different 
constructs caused CPEB to remain cytoplasmic when cells were incubated with 
LMB (Fig. 2-2B). To quantify the amount of CPEB that was nuclear or 
cytoplasmic, we determined the percent of cells with localization characteristics 
similar to those shown in Fig. 2-2C. The data compiled in Fig. 2-2D demonstrate 
that in the absence of LMB, all the CPEB proteins were predominantly 
cytoplasmic. In the presence of LMB, however, only deletion mutants 206-510 
showed significant cytoplasmic staining. These mutant proteins were designed to 
have molecular weights above 50 kD to minimize their free diffusion through the 
nuclear pore. Mutants showing no nuclear staining were in fact smallest in size, 
indicating that any nuclear protein accumulation was not a result of free diffusion. 
In addition, it should be noted that in cells treated with LMB, CPEB was 
predominantly, but not entirely nuclear, perhaps indicating that either the CPEB 
NLS is not as strong as the NLSs of other proteins or that there is some specific 
cytoplasmic retention. 
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To further define the CPEB NLS, deletion mutations spanning residues 
206 to 309 were generated, transfected into 3T3 cells that were then treated with 
LMB, and probed for HA as described above. Fig. 2-3A demonstrates that with 
the first set of deletions, CPEB ∆206-257 was evenly distributed in cells treated 
with LMB while CPEB ∆258-309 was strongly cytoplasmic. Consequently, we 
constructed the next set of proteins: CPEB ∆258-283 was uniformly distributed in 
cells treated with LMB while ∆284-309 was strongly cytoplasmic. In the next set 
of proteins expressed in cells treated with LMB, CPEB ∆284-296 was distributed 
throughout the cells while ∆297-309 and ∆297-307 was strongly cytoplasmic. 
To investigate further how residues 297-307 affected nuclear localization, 
each residue within peptide 297-307 was changed to alanine in separate 
constructs. When these were transfected into cells that were subsequently 
treated with LMB, all the ectopically expressed CPEBs became nuclear (Fig. 2-
3A and Supplementary Fig. 2-1). Thus, the deletion mutation but not the point 
mutation affected CPEB nuclear localization. 
CPEB residues 297-307 lie just upstream of RRMs (residues 310-510), so 
while RRM prediction algorithms do not indicate that they are a part of the RNA 
binding region, we nonetheless suspected that they might be involved in RNA 
binding. To assess this, 293T cells were infected with a retrovirus harboring HA 
tagged wild type or ∆297-307 CPEB (the 293T cells were employed because 
they express high amounts of exogenous CPEB compared to MEFs or other 
somatic cells); extracts derived from these cells were supplemented with 
radiolabeled RNA (mouse cyclin B1 3’ UTR) containing or lacking CPEs followed 
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by UV crosslinking and CPEB immunoprecipitation with antibody against HA and 
resolution by SDS-PAGE. On Western blots, two bands derived from the plasmid 
were evident; the lower band was the predicted size of CPEB (~68 kD) and the 
upper band could be the protein product from an upstream transcription start site 
(Fig. 2-3B, upper panel). CPEB WT crosslinked to the CPE containing but not 
CPE lacking RNA, whereas ∆297-307 did not crosslink to either of the RNAs (Fig. 
2-3B, lower panel). Thus, ∆297-307 was defective in both RNA binding and 
nuclear import, and it might imply that RNA binding is required for CPEB nuclear 
import. However, a zinc finger deletion mutant CPEB, which does not bind the 
CPE-RNA (Hake et al., 1998), entered the nucleus similar to WT (Fig. 2-2B, 2-
2D). Thus, we conclude from the NLS screening that while the proper folding of 
RRMs is important for both RNA binding and protein nuclear import, CPE-RNA 
binding is not essential for nuclear import. 
The complex nature of the CPEB NLS was also suggested by the 
observation that residues 206-309, when fused to luciferase, were unable to 
promote nuclear entry (data not shown), implying that the sequence information 
was not sufficient for nuclear import. Finally, although we have serially deleted 
CPEB in its entirety, we were unable to identify a nuclear export signal (NES). 
However, Ernoult-Lange et al., (2009) have recently identified two redundant 
NESs in CPEB. When leucine and isoleucine residues in the NESs (NES95-104 
LCLGLQSLSL and NES197-206 LSDLISSLRI) were replaced by alanine, CPEB 
accumulated in the nucleus independently of LMB treatment (Fig 2-4A). These 
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two NESs are conserved among vertebrate species, and the critical leucines are 
conserved in Drosophila (Fig. 2-4B). 
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Figure 2-2. CPEB nuclear localization domain. (A) Diagram of deletion mutant 
constructs of CPEB. PEST refers to a domain rich in proline, glutamic acid, 
serine and threonine that is thought to be involved in protein destruction; RRM 
refers to RNA recognition motif, and ZF refers to zinc finger. (B) 
Immunocytochemistry of 3T3 cells expressing CPEB-HA full-length or deletions 
illustrated in panel A. (C) The nucleus-cytoplasm localization was quantified 
using an arbitrary score; this scoring system was used to analyze the relative 
localization of the CPEB proteins shown in panel B. Histograms of these data are 
presented in (D); the numbers atop the bars refer to the total number of cells 
examined. 
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Figure 2-2 
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Figure 2-3. Requirement for CPEB nuclear localization and RNA binding. (A) 
CPEB deletion mutants lacking regions between residues 206 to 309 were HA 
tagged, transfected into NIH 3T3 cells, incubated in the presence of LMB, and 
analyzed as in Fig. 2-3. Residues 297-307 were necessary for nuclear 
localization; each of the 11 residues in this region was changed to alanine and 
the nuclear localization examined as above. In each case, single alanine 
substitutions had no effect on nuclear localization. (B) HEK 293T cells were 
infected with HA-tagged CPEB or CPEB ∆297-307. An extract was then prepared, 
supplemented with the CPE-containing cyclin B1 3’ UTR, UV irradiated, and 
subjected to HA immunoprecipitation. The proteins were then analyzed by 
western blot for HA (upper panel, two bands are evident; the higher one was 
likely generated from an upstream cryptic transcription start site of the C-pOZ 
vector.) and by autoradiography for proteins made radioactive by label transfer 
(lower panel). 
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Figure 2-3 
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Supplementary Figure 2-1. Point mutations in aa 297 – 307 did not affect the 
CPEB nuclear import. Mutant proteins accumulated in the nucleus after LMB 
treatment as the full-length CPEB.  
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Supplementary Figure 2-1 
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Figure 2-4. CPEB contains two redundant NESs in the N-terminal half of the 
protein. (A) When both of the NESs were mutated, CPEB1 accumulated in the 
nucleus independently of LMB treatment. (B) An alignment shows these two 
NESs are conserved among species. The critical leucine/isoleucine residues are 
also conserved in Drosophila orb1, but not other CPEB family proteins of any 
species (not shown).  
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Figure 2-4  
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CPEB associates with the nuclear RNA processing machinery 
To begin to determine the function of CPEB in the nucleus, we conducted 
a series of co-immunoprecipitation experiments. First, because symplekin 
appears to act as a scaffold protein upon which the CPEB-containing cytoplasmic 
machinery is assembled (Barnard et al., 2004; Kim and Richter, 2006), this 
protein was immunoprecipitated from the nucleus, where it is known to associate 
with the nuclear RNA processing machinery (Vethantham et al., 2007). 
Symplekin was immunoprecipitated from LMB-treated hand-isolated Xenopus 
oocyte stage VI nuclei (germinal vesicles) in the absence or presence of RNase 
A; the proteins that were co-precipitated were then identified by western blotting 
(Fig. 2-5A). CPEB was strongly co-precipitated with symplekin from the nucleus, 
as were CPSF 100 kDa subunit and cleavage stimulatory factor 64 (CstF64). 
RNA polymerase II was also co-precipitated, but cap-binding protein 80 (CBP80), 
PARN, PAB2 or actin either were not co-precipitated or were co-precipitated just 
barely above background, which could be due to nonspecific adsorption.  
Other oocyte nuclei were used for CPEB co-immunoprecipitation 
experiments. In this case, symplekin, Maskin, CPSF73, RNA polymerase II, and 
eIF4A3 were all co-precipitated irrespective of the presence of RNase A. CstF64, 
PARN, and actin were not co-precipitated significantly above background (Fig. 2-
5B). Moreover, CPEB was not co-precipitated with Gld2 (in this case, a 
heterologous myc-Gld2 fusion protein synthesized from injected mRNAs) (Fig. 2-
5C). Finally, Fig. 2-5D demonstrates that the hand isolation of oocyte nuclei was 
devoid of cytoplasmic contamination; tubulin, a cytoplasmic protein, was detected 
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only in the cytoplasmic fraction, while CBP80, a nuclear protein, was detected 
only in the nuclear fraction. These results indicate that CPEB resides in (a) 
complex(es) with specific components of the nuclear polyadenylation and RNA 
export machinery; they also suggest that its association with Maskin could be 
important for repressing translation once RNA is exported to the cytoplasm. 
Although CPEB is a sequence-specific RNA binding protein, it associates 
with some of the general RNA processing machinery in the nucleus, suggesting it 
might be deposited on mRNA without sequence specificity. To investigate this 
possibility, CPEB was immunoprecipitated from hand-isolated nuclei followed by 
RNA extraction and RT-PCR for specific CPE-containing and CPE-lacking RNAs. 
Fig. 2-5E shows that the CPE-containing RNAs cyclin B1, cyclin A1, cdk1, G10, 
wee1, and mos were all co-immunoprecipitated with CPEB. Conversely, none of 
the CPE-lacking RNAs, actin, eIF5, Rsp6, PIK3R1, was co-precipitated. Thus 
although CPEB associates with general RNA processing machinery, it is bound 
only to specific RNAs in the nucleus. 
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Figure 2-5. CPEB is a component of the nuclear RNA processing machinery. (A) 
Symplekin was immunoprecipitated in the absence or presence of RNase A from 
about 250 LMB-treated hand isolated oocyte nuclei. A similar number was mock 
precipitated with nonspecific IgG. The precipitates were probed on western blots 
for the proteins noted in the figure. Actin served as a negative control; 1% of the 
extract was also applied directly to the gel without immunoprecipitation. (B) 
Similar to panel A except that CPEB was immunoprecipitated from the nuclear 
extracts. (C) Oocytes were injected with mRNA encoding myc-tagged Gld2; 
following overnight culture, the nuclei were isolated and subjected to CPEB 
immunoprecipitation as in panel B and probed for the proteins noted in the figure. 
(D) Fractionation control from oocytes used in panels A-C and E; tubulin, a 
cytoplasmic protein, is entirely cytoplasmic, while CBP80, a nuclear protein, is 
entirely nuclear. (E) CPEB was immunoprecipitated from oocyte nuclei as before; 
the RNA was extracted from the precipitates and subjected to RT-PCR for the 
RNAs noted in the figure.  
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Figure 2-5 
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The nuclear experience of RNA and poly(A) metabolism 
 We considered a number of possible functions for nuclear CPEB including 
involvement in RNA processing (3’ end formation and splicing) and export. We 
also thought that nuclear CPEB might influence cytoplasmic polyadenylation 
and/or translation once the CPE-containing RNA was exported to the cytoplasm. 
To begin to examine these parameters, we injected plasmid DNA encoding 
luciferase fused to the cyclin B1 3’ UTR containing or lacking CPEs into oocyte 
nuclei (Fig. 2-6A). RNA derived from the injected DNA was exported to the 
cytoplasm with similar kinetics irrespective of the presence of CPEs (Fig. 2-6B). 
Thus, the CPE confers neither an advantage nor a disadvantage with respect to 
RNA biosynthesis or export. 
 When injected into the cytoplasm, CPE-containing RNA is deadenylated 
while CPE-lacking RNA is not (Kim and Richter, 2006, 2007). To determine 
whether the nuclear experience of RNA has an effect on deadenylation, RNA 
containing or lacking the CPE, polyadenylated in vitro with 100-120 adenylate 
residues, was injected into the nucleus or cytoplasm of oocytes (Fig. 2-6C). The 
RNA was then analyzed by gel electrophoresis 16 hours after injection. The RNA 
injected into the cytoplasm had a similar stability irrespective of the presence or 
absence of CPEs (Fig. 2-6D). Moreover, as reported previously (Kim and Richter, 
2006), the CPE-containing, but not CPE-lacking RNA was deadenylated when 
injected directly into the cytoplasm (frogs A and B, lane C, compare to probe 
p(A)). Surprisingly, however, when either RNA was injected into the nucleus, very 
strong deadenylation was evident (frogs A and B, lane N, compare to probe p(A)). 
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A short time course demonstrated that this deadenylation occurred very rapidly 
(within 20 minutes, independently of the CPE) and took place in the cytoplasm 
following nuclear export (data not shown). In contrast to these results, 
cytoplasmic CPE-containing RNA derived from injected plasmid DNA was 
deadenylated in the cytoplasm with similar kinetics compared to when CPE-
containing polyadenylated RNA was injected directly into the cytoplasm (Fig. 2-
6E. Note that the PCR-based PAT assay to detect RNA derived from the injected 
plasmid also detects the endogenous RNA; hence an RT-PCR signal is detected 
in the NI – noninjected – lane. The lower two panels of cytoplasmic and nuclear 
mRNA detect overall levels, both endogenous and ectopically expressed. The 
accumulation of cytoplasmic RNA is evident at 6 hours, the same time when 
polyadenylation of the RNA is observed). Thus, while these data do not show a 
difference in deadenylation between CPE-containing and CPE-lacking RNA, they 
do demonstrate that injected RNA is rapidly deadenylated when it is injected 
directly into the nucleus but not when it is derived from de novo transcription. We 
interpret these results to mean that a factor(s) is deposited on the poly(A) tail of 
nascent RNA that protects it from rapid removal and that such a factor(s) is not 
present on the poly(A) tail of RNA injected directly into the nucleus (see 
Discussion).  
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Figure 2-6. The nuclear experience of CPE does not mediate mRNA nuclear 
export or cytoplasmic deadenylation. (A) Diagram of experiment procedure for 
comparison of RNA export between CPE-containing and CPE-lacking luciferase 
mRNA. (B) Cytoplasmic luciferase mRNA levels following plasmid injection as 
determined by radioactive semi-quantitative RT-PCR (upper panel). The relative 
mRNA levels are graphed in the lower panel. (C) Diagram of experiment 
procedure for comparison of deadenylation between cytoplasm-injected and 
nucleus-injected cyclin B1 mRNA. (D) Deadenylation assay. A radiolabled and 
polyadenylated partial cyclin B1 mRNA was injected into the nucleus or 
cytoplasm of oocytes; after overnight incubation, the cytoplasmic fraction was 
collected for RNA extraction and analysis on a denaturing polyacrylamide gel. (E) 
Deadenylation assay of CPE-containing RNA. Oocytes were injected with in vitro 
transcribed RNA or plasmid DNA; RNA collected over several hours was 
analyzed by ligation-mediated PAT assay (see Material and Methods). Lower 
panels are ethidium bromide stained agarose gels showing RT-PCR products of 
cyclin B1 RNA; cyclin B1 mRNA started to accumulate ~3 hours after injection in 
the nucleus and ~6 hours in the cytoplasm. Note that because the RT-PCR does 
not distinguish endogenous from ectopic cyclin B1 3’ UTR, a band is present in 
the cytoplasmic fraction of noninjected oocytes. 
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Figure 2-6 
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The nuclear experience of CPEB and translational control 
 To determine whether the nuclear experience of CPEB could influence 
translation, we used the luciferase-cyclin B1 reporter system described in Fig. 2-
7A. Plasmid DNA encoding this construct, containing or lacking 3’ UTR CPEs, 
was injected into oocyte nuclei; 0-12 hours later, extracts were prepared and 
divided into two portions, one for luciferase assays and one for RNA 
measurement. A calculation of the translational efficiency of each construct 
(luciferase activity/mass amount of RNA), shows that CPE-lacking mRNA was 
much more efficiently translated than CPE-containing mRNA; by 12 hours, it was 
translated with ~10 fold greater efficiency (Fig. 2-7B). Similarly, the CPE-lacking 
mRNA (with ~100 base poly(A) tail) injected into the cytoplasm was translated 
more efficiently than the CPE-containing mRNA; by 12 hours, it was translated 
with ~3 fold greater efficiency (Fig. 2-7B). In both nuclear and cytoplasmic 
injection, no difference in the timing of when CPE-dependent translation 
repression took place was observed (both started 3 – 6 hr after injection). We 
next collected oocytes injected as in panel A that were incubated for 12-16 hours 
and calculated the relative translational efficiencies of CPE-lacking to CPE-
containing mRNA derived from nuclear or cytoplasmic injection (Fig. 2-7C). In 
this case, CPE-containing (WT) mRNA was more translationally repressed in a 
statistically significant manner compared to CPE-lacking mRNA (mt) when it 
experienced the nuclear milieu (translation efficiency mt/WT ~3 fold when 
injected in the cytoplasm, and ~6 fold when injected in the nucleus). We infer 
from these results that the binding of CPEB (and probably Maskin) to CPE-
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containing mRNA in the nucleus imposes a tight translational regulation in the 
cytoplasm.  
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Figure 2-7. The nuclear experience of CPE-containing mRNAs mediates tight 
translational repression. (A) Diagram of experimental procedure for comparing 
CPE-dependent translational repression with or without the nucleus experience. 
(B) Time course of translational efficiency of reporters (luciferase activity/RNA) 
containing or lacking CPEs derived from plasmid DNA injected oocytes (top). 
Time course of translational efficiency of the constructs noted above that were 
synthesized in vitro and then injected into the cytoplasms of oocytes (bottom). (C) 
Comparison of the translational efficiencies from panel B of plasmid injected 
nuclei versus RNA injected cytoplasm (dark grey bars). Also shown is a 
comparison of the translational efficiencies between RNA injected nuclei versus 
cytoplasm (light grey bars). The RNA was collected 12 to 16 hours after injection, 
and the translation efficiency was determined as in (B). The bars represent the 
fold difference of translational efficiency of RNA lacking the CPE (mt) divided by 
that of RNA containing the CPE (WT). Statistical analysis was by a one-tailed 
paired t-test. 
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Figure 2-7 
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CPEB and alternative splicing 
 Because CPEB shuttles to the nucleus where it associates with nascent 
transcripts (Fig. 2-1D), we considered the possibility that it might regulate 
alterative splicing as well as influence mRNA polyadenylation and translation. To 
investigate this possibility, we employed MEFs derived from WT and CPEB KO 
mice. RNA from 4 pairs of WT and KO MEFs were screened on an Affymetrix 
exon array platform (GeneChip Mouse Exon 1.0 ST Arrays). While bioinformatic 
analysis indicated a number of pre-mRNAs with skipped exons, we could validate 
only the one encoding collagen 9a1 (Col9a1). Fig. 2-8A shows three sets of WT 
and CPEB KO MEFs where exon 34 was skipped. The examination of tissue 
from WT and CPEB KO mice demonstrates exon 34 skipping in brain and ear, 
which has high collagen content (Fig. 2-8B). However, the effect of CPEB on 
Col9a1 splicing was not the same in all tissues. For example, in testis, exon 35, 
instead of exon 34, was preferentially skipped in the absence of CPEB, whereas 
in heart, exon 35 was skipped independent of CPEB. These results demonstrate 
that CPEB mediates alternative pre-mRNA splicing, although they do not indicate 
whether this is a direct effect. 
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Figure 2-8. CPEB mediates alternative pre-mRNA splicing. (A) RT-PCR (dCTP-
[α-P32] incorporation) analysis of exons 33-36 of the collagen 9a1 mRNA from 3 
different WT and CPEB KO MEF lines. (B) RT-PCR analysis of collagen 9a1 
mRNA exons 33-36 from different tissues of WT and CPEB KO mice. 
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Figure 2-8 
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Discussion 
 
 In this study, we demonstrate that CPEB shuttles between the nucleus 
and cytoplasm, that it has a complex NLS, that it along with RNA processing 
machinery associates with RNA in the nucleus, and that its nuclear experience is 
important for repressing translation in the cytoplasm. As depicted in Fig. 2-9, we 
envisage that CPEB forms RNPs with nascent RNAs, and these RNPs include, 
among other factors, eIF4A3, CPSF and Maskin. These factors may also be 
associated with RNA polymerase II. The RNP is exported to the cytoplasm where 
it reforms with components of the cytoplasmic polyadenylation machinery 
including Gld2, PARN, symplekin and CPSF.  
We propose that the association of CPEB and Maskin with RNA in the 
nucleus is important for translational silencing upon export to the cytoplasm. The 
RNP resides in this translationally dormant state until progesterone signaling 
induces activation of the kinase Aurora A, which phosphorylates CPEB, leading 
to the expulsion of PARN from the RNP complex. This event results in Gld2-
catalyzed polyadenylation and subsequent translation.  
 We also used MEFs derived from CPEB knockout mice to demonstrate 
that CPEB influences specific alternative splicing. While we do not know if CPEB 
acts directly or indirectly to regulate nuclear RNA processing, these data 
demonstrate that CPEB modulates gene expression at multiple levels and does 
not solely control cytoplasmic polyadenylation and translation. Therefore, the 
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biological consequences of the loss of CPEB could in part be due to defective 
splicing as well as defective translation. 
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Figure 2-9. Model of CPEB-mediated translational control. A CPE-containing 
RNA is recognized by a CPEB and Maskin-containing protein complex in the 
nucleus either co-transcriptionally or soon after transcription is complete. After 
export from the nucleus, a cytoplasmic RNP complex is assembled that includes 
the poly(A) polymerase Gld2 and the deadenylating enzyme PARN. PARN is 
expelled from the complex upon progesterone-induced and aurora A-catalyzed 
CPEB phosphorylation; Gld2 then elongates the poly(A) tail by default. Maskin is 
phosphorylated at this time. These events, as well as its association with an 
embryonic poly(A) binding protein (not shown), lead to the replacement of Maskin 
for eIF4G on eIF4E. As a consequence, translation is activated. The association 
of eIF4A3 with the cytoplasmic complex is conjectural. 
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Figure 2-9 
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RNA nuclear and cytoplasmic regulation 
Over the past decade, several lines of evidence have emerged showing 
that nuclear RNA processing events influence the cytoplasmic fates of mRNAs. It 
was originally suggested by Braddock et al. (1990) that a factor that blocks 
translation could be deposited on mRNA prior to export. In a similar vein, Bouvet 
and Wolffe (1994) showed that transcription is involved in relaying a negative 
translation factor to nascent RNA in the nucleus. More recently, it was reported 
that the reporter plasmid DNAs used as templates for the synthesis of mRNA 
affected the mechanism by which miRNAs repress translation (Kong et al., 2008), 
presumably due to different factors associated with newly transcribed RNAs that 
contain sites complementary to miRNA. Moreover, RNA splicing seems to be 
particularly important for regulating mRNA localization and translation. For 
example, insertion of a 5’ intron into an intronless gene enhances translation of 
the derived mRNA by ten fold (Matsumoto et al., 1998). Molecules deposited 
during splicing, such as the EJC components eIF4A3, Y14 and Mago, are 
responsible for mRNA localization and following translational control (Hachet and 
Ephrussi, 2004; Palacios et al., 2004). The EJC is also involved in nonsense-
mediated mRNA decay (NMD), a cytoplasmic process. In this case, EJC 
components including UPF2 and UPF3 reside 20-24 bases 5’ of exon-exon 
junctions. They recruit and/or activate ribosome-associated UPF1, which 
ultimately induces NMD. Thus, NMD would be activated during an initial 
translational event (i.e., the “pioneer” round) (Maquat, 2004; Brogna and Wen, 
2009). In addition to NMD components, shuttling hnRNP proteins must also 
68 
 
experience a nuclear milieu to affect, at least the case of hnRNP D, cytoplasmic 
RNA stability (Chen et al., 2004).  
CPEB is also deposited on nuclear RNAs, but only those that contain a 
CPE (Fig. 2-5E). This would seem to be paradoxical given our other observations 
that show CPEB to be a component of the general RNA processing machinery 
such as RNA polymerase II and CPSF. This implies that the so-called general 
machinery may be associated with specific components. Such specific 
components may be transiently associated with the general machinery that could 
lend it diversity. Notably, there appears to be considerable remodeling of RNPs 
in the nucleus of cells, or when the RNPs enter the cytoplasm. For example, 
RNA localization in the vegetal cortex of the Xenopus oocyte cytoplasm is 
initiated by interactions with RNA binding proteins in the nucleus (Kress et al., 
2004), at least with the protein Vg1RBP/vera. Moreover, PTB/hnRNP I plays a 
critical role in this process by coordinating and remodeling the association of 
Vg1RBP/Vera with the Vg1 target mRNA (Lewis et al., 2008). While we do not 
propose a remodeling activity for CPEB, these examples make clear that 
dynamic changes among RNA binding proteins occur as RNAs undergo nuclear 
export. 
We suspected that the interaction of CPEB with nuclear RNA might 
facilitate the CPE-dependent cytoplasmic deadenylation. Therefore, we 
compared the efficiencies of the deadenylation process between nuclear and 
cytoplasm-injected RNA (Fig. 2-6). However, the in vitro transcribed RNA 
injected into the nucleus was rapidly cleaved and/or degraded while the little 
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amount that was exported to the cytoplasm was rapidly deadenylated 
irrespective of a CPE. We hypothesize that the injected RNA would not be 
associated with a factor, for example, nuclear poly(A) binding protein, that would 
be deposited on nascent RNA during transcription or soon thereafter. In the 
absence of this factor, surveillance may be triggered to destroy the RNA. Such a 
surveillance mechanism would apply only to the nucleus since in the cytoplasm, 
CPE-lacking RNAs contain stable poly(A) tails following cytoplasmic injection. 
 
An additional function of CPEB: alternative splicing 
While nuclear CPEB (and Maskin) binds RNA in the nucleus to tightly 
regulate translation in the cytoplasm (Fig. 2-7C), our data suggest that CPEB is 
also involved in splicing regulation (Fig. 2-8). Because the sequences near the 
intron-exon boundary of alternative exon (exon 34 of Col9a1) contain CPEs, we 
surmised that CPEB might directly control alternative processing. Consequently, 
we generated a minigene containing exon 34 surrounded by ~500 bases of intron 
sequence; however, when co-transfected with heterologous CPEB, we could 
detect no change in its splicing pattern. Moreover, over-expression of CPEB in 
KO MEFs also did not rescue the splicing pattern of endogenous Col9a1 pre-
mRNA (data not shown). We are unsure whether the sequence information of the 
minigene was sufficient to direct splicing or why overexpression of CPEB failed to 
induce the alternative splicing. We would expect the expression of CPEB to 
rescue the WT splicing pattern, even if CPEB was acting indirectly to induce 
exon skipping. Skipping exon 34 of Col9a1 does not result in a frameshift; 
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however, it should be noted that the alternative exon usage revealed by exon 
array analysis could simply reflect changes in the stability of the respective 
mRNAs. 
 
The complex nature of nuclear localization of CPEB 
Recently, Ernoult-Lange et al. (2009) have also shown that CPEB traffics 
to the nucleus, in this case, in HeLa cells. Those investigators also found CPEB 
to be associated with nuclear foci that they referred to as Crm1 nucleolar bodies. 
Using HA-tagged CPEB, we have been unable to confirm these findings; we did 
not observe CPEB in any discreet region in the nucleus. However, because 
those investigators employed GFP-CPEB for this identification, we thought that 
perhaps the tag used to identify heterologus CPEB could influence is subcellular 
localization. Consequently, we fused GFP to CPEB and repeated our 
experiments; again we could not identify discreet sub-nuclear regions where 
CPEB accumulated. We do not know why these localization results differ from 
those of Ernoult-Lange (2009). 
 We have found that the RRMs of CPEB are involved in nuclear import. 
While we did not identify a canonical NLS in this region, we nonetheless replaced 
several positively charged residues with alanine; none elicited a defect in nuclear 
import (data not shown). We hypothesize that the proper folding of RRMs, and 
hence CPEB’s interaction with other factors, is necessary for efficient nuclear 
import. Irrespective of the precise nature and sequence of the CPEB NLSs, we 
identify two new functions for CPEB: it associates with mRNP in the nucleus to 
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reinforce cytoplasmic translational repression, and it regulates alternative splicing 
of a specific pre-mRNA.  
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Material and Methods 
 
Antibodies 
Antibodies used in this study include: rabbit anti-CPEB (Hake and Richter, 
1994), rabbit anti HA (Covance), mouse anti-α-tubulin (Sigma-Aldrich), rabbit 
anti-histone H4 (Upstate), mouse anti-symplekin (BD Transduction Laboratories), 
mouse anti-RNA polymerase II 8WG16 (Upstate), rabbit anti-CPSF73 (gift of D. 
Bentley, University of Colorado), rabbit anti-CPSF100 (Takagaki and Manley, 
2000; gift of J. Manley, Columbia University), rabbit anti-CstF64 (Shell et al., 
2005; gift of C. Milcarek, University of Pittsburgh), rabbit anti-CBP80 (Izaurralde 
et al., 1994; gift of E. Izaurralde, Max Planck Institute), rabbit anti-PARN (gift of M. 
Wormington, University of Virginia), rabbit anti-PAB2 (Krause et al., 1994; gift of 
E. Wahle, University of Halle), mouse anti-actin, rabbit anti-Maskin (Stebbins-
Boaz et al., 1999), mouse anti-eIF4A3 (gift of A. Krainer, Cold Spring Harbor 
Laboratory) and mouse anti-myc 9E10 (Hake and Richter, 1994). 
 
Immunocytochemistry 
3T3 cells were seeded to about 50% confluency on the coverslip the day 
before infection. Mouse CPEB-containing virus made from the C-pOZ retroviral 
system (Groisman et al., 2006) was filtered and applied to the 3T3 cells. After 
overnight incubation to allow protein expression, the cells were washed twice 
with PBS and fixed with 4% paraformaldehyde in cytoskeleton buffer (10 mM 
PIPES pH 6.8, 300 mM sucrose, 100 mM NaCl, 3 mM MgCl2 and 1 mM EGTA) 
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10 min at room temperature (RT). The cells were washed with PBS and then 
permeabilized with 0.5% Triton X-100 in cytoskeleton buffer 5 min at RT. After 
washing twice, the cells were blocked in TBS-1 (10 mM Tris-HCl pH 7.7, 150 mM 
NaCl, 3 mM KCl, 1.5 mM MgCl2. 0.05% Tween 20, 0.1% bovine serum albumin 
[BSA], 0.2% glycine) supplemented with 10% goat serum for at least 30 min. 
After blocking, the cells were incubated with HA antibody (1:1000) in PBS-1 with 
goat serum for 1 hr, followed by 5 washes in PBS. The cells were then incubated 
in fluorescence-conjugated secondary antibody for 1 hr. Following 3 washes, the 
cells were stained with DAPI to visualize the nucleus; they were mounted in 
Prolong® Gold antifade reagent (Invitrogen). 
 
Lampbrush chromosomes 
The nucleus was dissected from stage VI oocytes in 5:1 isolation buffer 
(83 mM KCl, 17 mM NaCl, 6.5 mM Na2HPO4, 3.5 mM KH2PO4, 1 mM MgCl2 and 
1 mM DTT) and transferred to coverslips with wax wells containing dispersal 
buffer (20.7 mM KCl and 4.3 mM NaCl). After removing the nuclear membrane to 
liberate the nuclear matrix, the chromosomes were allowed to spread for 30 min. 
The chromosomes were centrifuged onto glass slides at 2,000g for 10 min and 
then fixed in cold methanol for 20 min. Following several washes, the 
chromosome preparation was blocked in 2% BSA in PBS for 30 min at RT 
followed by immunocytochemistry.  
 
Immunoprecipitation 
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CPEB and symplekin antibodies as well as control IgG were conjugated to 
protein A-sepharose 4B (Invitrogen) or anti-mouse dynabeads (Invitrogen) 
overnight at 4 ºC, and washed to remove free antibodies. 500 to 1000 nuclei from 
stage VI oocytes were homogenized in IP buffer (150 mM NaCl, 25 mM HEPES-
KOH pH 7.5, 10% glycerol, 1 mM MgCl2, 2 mM sodium orthovanadate, 2 mM β-
glycerophosphate, 1 mM phenylmethylsulphonylfluoride [PMSF], 1 mM DTT, 2 
mM EDTA, 0.5% Triton X-100 and protease inhibitor cocktail [Roche]). The 
oocyte lysate was precleared and incubated with antibody-conjugated beads 
overnight at 4 ºC with or without 50 μg/ml RNase A (Sigma-Aldrich) as indicated. 
The collected beads were then washed 5 times before boiling in SDS-sample 
buffer. 
 
RNP-IP 
2000 to 3000 LMB treated hand isolated nuclei were homogenized in 
RNP-IP buffer (150 mM NaCl, 25 mM Tris-HCl pH 7.5, 1 mM DTT, 1 mM PMSF, 
2 mM MgCl2, 10% glycerol, 0.5% Nonidit P-40, protease inhibitor cocktail, and 
100 units/ml RNaseOUT [Invitrogen]) and precleared with IgG-conjugated beads 
for 30 min before incubated with antibody-conjugated beads for 3 hours. The 
beads were washed four times, treated with 5 units of DNase I for 15 min at 30 
ºC, and then the RNA on the beads was extracted by Trizol (Invitrogen). The 
purified RNA was subject to RT-PCR with the following primers: for cyclin B1 5’-
GCATATGGCCAAGAACATCATCAAGG-3’ and 5’-
CATGTTAAAATGAGCTTTATTAAAACCAG-3’; for cyclin A1 5’-
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CACCAATTCTGTCTTGGTGC-3’ and 5’-CAGTTGAGGGGAAGTATTGA-3’; for 
cdk1 5’-CCAAGTGGATCCGACAAGAC-3’ and 5’-
CAGCGCTACTTTAGCAGAAAT-3’; for G10 5’-
CAACTTTGGAACCAACTGTATT-3’ and 5’-CCAGAAGTCAGTTAGAATTGC-3’; 
for wee1 5’-CTCCAGAAACAGCTCAATGT-3’ and 5’-
AACACTCGTCCTTCCCAGAA-3’; for mos 5’-CCATGGGGCAATTCATACCA-3’ 
and 5’-GGCCCATTCACACTTCTGAT-3’; for actin beta 5’-
GAATGCAGAAAGAAATAACTGC-3’ and 5’-TGGAGCCACCAATCCAGAC-3’; for 
eIF5 5’-GCAAAGAGAAAGAAAATGGTTC-3’ and 5’-
GCGTCTCTGAGCCTCTGC-3’; for Rsp6 5’-GAAGCAGCGTACTCAAAAGAA-3’ 
and 5’-AGCCTGCGCCTCTTCGC-3’; for PIK3R1 5’-
TCCTTGTGCGAGAGAGCAG-3’ and 5’-GAACCCAAAACCAGTATGCG-3’. 
 
UV crosslinking and immunoprecipitation 
HEK 293T cells were infected with retrovirus carrying CPEB-HA or ∆297-
307 CPEB-HA and incubated overnight to allow protein expression. The cells 
were homogenized in IP buffer (see above) and incubated with 2 X 106 cpm of 
mouse cyclin B1 3’ UTR (containing CPEs; in some cases, the CPEs were 
mutated) in 2X gel retardation buffer (20 mM HEPES pH 7.6, 2 mM MgCl2, 0.2 
mM ZnCl2, 100 mM KCl, 20% glycerol and 2 mM DTT) supplemented with 2.5 
mg/ml heparin, 50 μg/ml tRNA, 0.5 mM DTT and 0.6 unit/μl RNaseOUT, 10 min 
on ice and 10 min at RT. The protein-RNA mixture (20 μl) was applied per well 
on a NunclonTM ∆ Surface plate (NuncTM) and UV-irradiated with 440 mJ 
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(Stratalinker UV Crosslinker, Strategene) on iced water. Following 2 μg RNase A 
treatment at 37 °C for 30 min, the mixture was subject to IP with anti-HA antibody 
followed by boiling in SDS sample buffer and analysis by western blotting and 
autoradiography. 
 
Deadenylation assay 
In vitro transcription using mMESSAGE mMACHINE® T7 Ultra (Ambion) 
from linearized pBSSK-xCCNB1C WT or CPE mutant plasmid was performed 
with 20 μCi UTP-[α-P32]. The mRNA was polyadenylated with E. coli poly(A) 
polymerase (Ambion) followed by LiCl precipitation. About 103 cpm of 
polyadenylated mRNA was injected into the nucleus or the cytoplasm of stage VI 
oocytes. After incubation, the mRNA was recovered in PAS buffer (0.1 M Tris pH 
7.6, 1% SDS, 6% p-Aminosalicylic Acid (PAS) and 1 mM EDTA pH 8) and 
extracted with phenol/chloroform. The purified mRNA was analyzed on 4% 
denaturing polyacrylamide gel (SequaGel® Sequencing System, National 
Diagnostics) and visualized using a phosphoimager.  
For analysis of in vivo transcribed RNA, a ligation-mediated PAT assay 
was performed (Rassa et al., 2000). RNA extracted from injected oocytes was 
ligated to 0.5 μg of P1’ primers (5’-P-GGTCACCTTGATCTGAAGC-NH2-3’) using 
T4 RNA ligase at 37 °C for 30 min and inactivated at 95 °C for 5 min. The RNA 
was subjected to an RT reaction with P1-Anchor primer (5’-
GCTTCAGATCAAGGTGACCTTTTT-3’), followed by RNase H digestion. The 
cDNA was used for PCR with P1-Anchor primer and xCCNB1-f(PAT) primer (5’-
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GTGGCATTCCAATTGTGTATTGTT-3’), supplemented with dATP-[α-P32]. The 
PCR product was resolved on a 4% polyacrylamide gel. 
 
Exon array analysis 
Four pairs of WT and CPEB1 KO male MEFs from the same litter were 
collected at passage 3 to 5. The RNA was purified using Qiagen RNeasy Mini Kit 
and its integrity was examined by gel electrophoresis. The microarray 
hybridization (Affymetrix GeneChip Mouse Exon 1.0 ST Arrays) was carried out 
at the Protein and Nucleic Acid Facility of Stanford School of Medicine. Statistical 
analysis was performed according to published procedures (Xing et al., 2006; 
Xing et al., 2008). The inclusion of exon 34 of Col9a1 was validated by RT-PCR 
with primers: 5’-GGAGATATGGGACAACCTGG-3’ and 5’-
GCTGGCTGCCATTTCCGC-3’. 
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Abstract 
 
During oocyte development, the cytoplasmic polyadenylation element-
binding protein (CPEB) nucleates a set of factors on mRNA that controls 
cytoplasmic polyadenylation and translation. The regulation of polyadenylation is 
mediated in part through serial phosphorylations of CPEB, which control both the 
dynamic integrity of the cytoplasmic polyadenylation apparatus and CPEB 
stability, events necessary for meiotic progression. Because the precise 
stoichiometry between CPEB and CPE-containing RNA is responsible for the 
temporal order of mRNA polyadenylation during meiosis, we hypothesized that if 
CPEB production exceeded the amount required to bind mRNA, the excess 
would be sequestered in an inactive form. One attractive possibility for the 
sequestration is protein dimerization. We established that not only does CPEB 
form a dimer, but dimerization requires its RNA-binding domains. Dimer 
formation prevents CPEB from being UV crosslinked to RNA, which establishes a 
second pool of CPEB that is inert for polyadenylation and translational control. 
During oocyte maturation, the dimers are degraded much more rapidly than the 
CPEB monomers, due to their greater affinity for polo-like kinase 1 (plx1) and the 
ubiquitin E3 ligase β -TrCP. Because dimeric CPEB also binds cytoplasmic 
polyadenylation factors with greater affinity than monomeric CPEB, it may act as 
a hub or reservoir for the polyadenylation machinery. We propose that the 
balance between CPEB and its target mRNAs is maintained by CPEB 
dimerization, which inactivates spare proteins and prevents them from inducing 
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polyadenylation of RNAs with low affinity binding sites. In addition, the dimers 
might serve as molecular hubs that release polyadenylation factors for 
translational activation upon CPEB dimer destruction. 
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Introduction 
 
In early development, many maternal mRNAs are translationally 
repressed in oocytes that are arrested at the end of meiosis prophase I. In 
response to a hormonal cue, the oocytes re-enter the meiotic divisions (indicated 
by germinal vesicle break down or GVBD) and commensurately activate the 
dormant mRNAs. A key regulator for both translational activation and meiotic 
progression is the cytoplasmic polyadenylation element-binding protein CPEB, 
which binds cytoplasmic polyadenylation elements (CPEs), U-rich structures (U4-
6A1-2U1-2) in the 3’ untranslated regions (UTRs) of responding mRNAs (Richter, 
2007). CPEB not only binds RNA, but also recruits both the poly(A)-specific 
ribonuclease PARN and the non-canonical poly(A) polymerase Gld2 (defective in 
germline development 2) to the ribonucleoprotein (RNP) complex. PARN and 
Gld2 are both active yet their antagonistic activities result in short poly(A) tails 
and translational quiescence (Kim and Richter, 2006). Another group of factors 
that interacts with the CPEB-containing complex includes symplekin, cleavage 
and polyadenylation specific factor (CPSF) complex, maskin, and eukaryotic 
initiation factor eIF4E (Richter, 2007). Maskin binds eIF4E and inhibits the 
assembly of the initiation complex on the 5’ cap (Stebbins-Boaz et al., 1999; Cao 
et al., 2006). Upon re-entry into meiosis, a signaling cascade initiated by 
progesterone binding to a surface-associated receptor results in activation of the 
kinase aurora A (Mendez et al., 2000a), which in turn phosphorylate CPEB. 
Phosphorylated CPEB induces the expulsion of PARN from the RNP (Kim and 
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Richter, 2006) and enhances the association with CPSF (Mendez et al., 2000b), 
leading to Gld2-catalyzed polyadenylation and translation (Barnard et al., 2004; 
Kim and Richter, 2006). 
In addition to polyadenylation-induced translation, progesterone also 
stimulates activation of cyclin–dependent kinase 1 (cdk1)/RINGO (rapid inducer 
of G2/M progression in oocytes) complex, which hyper-phosphorylates CPEB 
and elicits i) binding of the embryonic poly(A) binding proteins (ePAB) to the 
poly(A) tail to stabilize the tail (Kim and Richter, 2007) and ii) partial destruction 
of CPEB (Mendez et al., 2002). CPEB possesses a TSG motif (190TSGFSS195) in 
the PEST domain (a proline, glutamic acid, serine, and threonine-rich sequence 
typical of short-lived proteins) that resembles the binding site of the F-box protein 
of ubiquitin E3 ligase complex, β-transducin repeat-containing protein (β-TrCP). 
(The conventional β-TrCP binding site is a doubly phosphorylated DSG motif, 
DpSGΦXpS, where Φ represents a hydrophobic amino acid and X represents 
any amino acid [Fuchs et al., 2004]). A polo-like kinase homologue plx1 
recognizes one of the cdk1 phosphorylation sites on CPEB and in turn 
phosphorylates the TSG motif, which then recruits β -TrCP for proteosome-
mediated protein destruction (Setoyama et al., 2007). CPEB is therefore largely 
degraded when the oocytes undergo the prophase I to metaphase I transition 
(i.e., oocyte maturation), and remains relatively low in amount throughout the 
early embryonic stages. Paradoxically, the low level of CPEB is indispensible for 
the late maturation phase of CPEB-mediated translational activation. That is, if 
non-degradable CPEB mutants are introduced into the cell, it cannot proceed to 
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meiosis II (Mendez et al., 2002), suggesting that a low CPEB to CPE ratio is 
critical to activate the translation of mRNAs for progression to meiosis II. 
Protein dimerization or multimerization can be a regulatory mechanism to 
increase the diversity of catalytic dynamics without increasing the genetic burden. 
Several RNA binding proteins are reported to form homo-dimers or multimers, 
including FMRP (fragile X mental retardation protein) (Adinolfi et al., 2003), 
quaking (Chen and Richard, 1998), staufen 1 (Martel et al., 2010), ELAV 
(embryonic lethal abnormal visual) family proteins (Toba and White, 2008), and 
She2p (Muller et al., 2009). Dimerization often involves heavily structured 
domains, among which are RNA-binding domains. A number of reports suggest 
that protein dimerization or multimerization is required for RNA binding, 
interaction with other proteins, translational regulation, or localization (Faller et al., 
2007; Muller et al., 2009). These studies indicate that the α-helices of the RNA 
recognition motifs (RRMs) could form the basis of dimer formation yet still not 
interfere with the RNA binding that takes place on the opposite surface of β-sheet 
(Jang et al., 2006). In contrast, other investigators find that only the monomeric 
forms of RNA-binding proteins can bind RNA (Cole et al., 1993), and that the 
RRMs are used for protein-protein recognition instead of RNA recognition 
(Fribourg et al., 2003; Yao et al., 2007). Based on these studies, 
dimerization/multimerization is a common feature that introduces regulatory 
complexity, but the biochemical result, to bind or not bind RNA, may be protein-
dependent. 
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Aplysia CPEB has been reported to harbor prion-like properties; that is, 
the ability to form amyloidogenic self-sustaining multimers, which is mediated by 
neuronal activity (Si et al., 2010). A Q-rich stretch (66 Q’s from amino acid 53 to 
139) at the N terminus is essential for the multimerization; however, vertebrate 
CPEB proteins contain no such Q-rich sequences. Instead, the C terminal half of 
all CPEB proteins is heavily structured, including two RRMs and two zinc fingers 
(ZFs), all of which are necessary for efficient RNA binding (Hake et al., 1998). 
Here, we provide evidence that CPEB forms dimers through the RNA-binding 
domains, which abrogates RNA binding; moreover, this dimerization is regulated 
during meiosis. We show that CPEB dimers have a strong affinity for 
polyadenylation factors and the protein destruction machinery, and thus may 
serve as a molecular reservoir in which its degradation may release components 
of the polyadenylation apparatus for translational activation. Finally, we 
demonstrate that excess CPEB monomers, but not dimers, are deleterious to 
meiotic progression. We hypothesize that CPEB dimers serve two purposes: to 
fine-tune the amount of CPEB that is required for oocyte maturation, and to act 
as a hub for polyadenylation factors that are released during maturation when the 
dimer is destroyed.   
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Results 
 
CPEB forms a dimer in oocytes in a cell cycle-dependent manner 
 We noticed that western blots of oocyte extracts probed for CPEB would 
sometimes yield two species of immunoreactivity, a fast migrating form that 
corresponded to the size of full-length CPEB (~65kDa) and a slower form that 
was double in size (~130 kDa); these two species were particularly evident if the 
protein loading buffer contained reduced amounts of SDS (<1%). Fig. 3-1A 
shows this relationship over a concentration range of SDS in the loading buffer 
with and without boiling the sample. With the standard 2% SDS and boiling the 
sample, almost all the CPEB immunoreactivity had the expected mobility of ~65 
kDa. With reduced SDS or the elimination of sample boiling, the 130 kDa species 
became readily apparent. Substitution of the lysis buffer SDS with sarkosyl, a 
mild detergent, also yielded the two species (sample boiling with sarkosyl caused 
most of the protein to remain in the well). Treatment of the samples with double 
the amount (4%) of SDS reduced the 130 kDa CPEB immunoreactive species 
(Fig. 3-1B, left), suggesting that the 130 kDa band was not a result of nonspecific 
crossreactivity. Further treatment of the samples with dithiothreitol (DTT, without 
β -mercaptoethanol), or RNase indicated that the 130 kDa CPEB 
immunoreactive species was stabilized by disulfide bonds but did not require 
RNA for the reduced electrophoretic mobility (Fig. 3-1B, middle and right). Finally, 
to determine whether the 130 kDa species was specific for the oocyte or involved 
proteins other than CPEB, a rabbit reticulocyte lysate was primed with mRNA 
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encoding either luciferase or HA-tagged CPEB and supplemented with 35S-
methionine. Fig. 3-1C shows that the 65 and 130 kDa species were both evident 
when CPEB RNA was translated in the extract, which was further confirmed by 
western blotting with the HA antibody. These results suggest that the 130 kDa 
species contains CPEB and has the electrophoretic migration expected of a 
dimer.  
 To determine whether the 130 kDa band is indeed a CPEB dimer, human 
embryonic kidney (HEK) 293T cells were co-transfected with constructs encoding 
CPEB-FLAG and CPEB-HA, which was followed by FLAG or HA 
immunoprecipitation (IP) and western blotting for both epitopes. Fig. 3-2A shows 
that IP with HA or FLAG antibody precipitated CPEB with both epitopes, 
indicating that the CPEB proteins interacted. In addition, treatment of CPEB-HA 
expressing HEK 293T cells with 2-fold increasing concentrations of formaldehyde 
followed by western blotting for HA shows that high molecular weight species of 
CPEB corresponding in size to that of a predicted dimer gradually formed. Large 
aggregates were apparent at the higher formaldehyde concentrations (Fig. 3-2B). 
Similar formaldehyde crosslinking experiments were carried out with cells co-
expressing CPEB-FLAG and CPEB-HA; again, dimer size CPEB-HA was co-
immunoprecipitated with FLAG antibody even under very stringent washing 
conditions (Fig. 3-2C, also see Materials and Methods), suggesting that CPEB-
FLAG and CPEB-HA were in close physical proximity to be covalently 
crosslinked. Taken together, the data in Fig. 3-2 demonstrate that CPEB can 
dimerize. 
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 To determine the dimerization status of native CPEB, we performed gel 
filtration of lysates from dormant stage VI oocytes or mature oocytes that had 
undergone GVBD during the meiotic divisions. Using symplekin (150 kDa), 
PARN (74 kDa and 62 kDa), and tubulin (55 kDa) as size markers, Fig. 3-3A 
shows that CPEB was predominant in high molecular complexes (>150 kDa); 
CPEB from the dormant oocytes was also evident in fractions that corresponded 
to dimer, but not monomer, in size. In contrast, CPEB from mature oocytes (P-
CPEB), while still mostly in high molecular complexes, was mostly absent from 
the fractions corresponding to the dimer size but displayed a light peak at the 
monomer size. These data suggest that the CPEB dimers undergo a 
rearrangement or destruction during maturation. This possibility is also indicated 
by the data in Fig. 3-3B, which show that under conditions of low SDS, dormant 
oocytes contained both CPEB monomer and dimer as presented previously, but 
mature oocytes contained only CPEB monomers. These results suggest that 
CPEB dimerization is regulated during meiotic progression. 
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Figure 3-1. CPEB migrates at 65 kDa and 130 kDa in a mild denaturing SDS-
PAGE. (A) CPEB immunoreactive 130 and 65 kDa bands were observed when 
oocyte lysates were prepared with low SDS-containing sample buffer, with 
sarkosyl instead of SDS, or when the sample was not boiled. (B) Oocyte lysate 
were prepared with various amounts of SDS, sulfhydryl reducing agent, or 
RNase to characterize the 130 kDa CPEB immunoreactive band. Left two lanes: 
the 130 kDa band was sensitive to higher concentrations of SDS, suggesting that 
it is composed of two or more polypeptides. Middle two lanes: the 130 kDa band 
was sensitive to the DTT sulfhydryl reducing agent, suggesting that a disulfide 
bond is involved in protein stabilization. Right two lanes: the 130 kDa band was 
not sensitive to RNase treatment, suggesting that its formation is RNA-
independent. (C) mRNAs encoding HA-CPEB and luciferase were translated in a 
rabbit reticulocyte lysate supplemented with 35S-methionine The lysate was then 
directly applied to SDS-PAGE and visualized by both autoradiography and 
western blotting. HA-CPEB migrates as two major species, one at 130 kDa and 
the other at 65 kDa.  
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Figure 3-1 
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Figure 3-2. CPEB forms a dimer in mammalian cells. (A) CPEB-HA and CPEB-
FLAG were co-expressed in HEK 293T cells followed by reciprocal co-
immunoprecipitation (IP) with HA or FLAG antibodies and western blotting with 
the same antibodies. These co-IPs demonstrate that CPEB forms a dimer. Actin 
served as an IP and loading control. (B) Extracts from CPEB-HA transfected 
HEK 293T were incubated with increasing amounts of formaldehyde, which was 
followed by immunoblotting for the HA epitope. Note that with lower 
formaldehyde, a 130 kDa CPEB band was evident, which is the size of a CPEB 
dimer. N.T. refers to nontransfected. (C) CPEB-HA and CPEB-FLAG were co-
expressed in HEK 293T cells and crosslinked with 0.12% formaldehyde as in 
panel B. Stringent IP conditions were applied to minimize possible nonspecific 
adducts. The precipitate was then subjected to western blotting with antibody for 
the HA and FLAG epitopes. 
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Figure 3-2 
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Figure 3-3. Dimeric CPEB undergoes maturation-mediated destabilization in the 
native condition. (A) To examine the native status of CPEB, clarified lysate from 
dormant or GVBD oocytes were passed through a size exclusion column. 
Fractions of eluates were then assessed by western blotting. Although most of 
CPEB was in complexes larger than 150 kDa, in the dormant oocyte, there was a 
population of CPEB fractionating around 130 kDa, potentially the dimers. In 
GVBD oocytes (P-CPEB), only a light peak around 65 kDa, the monomer size, of 
CPEB could be detected, and the 130 kDa peak was not observed. These data 
suggest that in the GVBD cells, CPEB undergoes an alteration such that the free 
dimeric CPEB is no longer stable. (B) Extracts from stage VI oocytes and GVBD 
oocytes were assessed by SDS-PAGE with low SDS in the sample buffer. The 
slow migrating CPEB species about 130 kDa is evident from stage VI oocytes, 
but not from GVBD oocytes.  
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Figure 3-3 
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CPEB dimerization requires RNA binding regions 
 To determine the structural requirements for dimerization, serial deletions 
of CPEB were generated (Fig. 3-4A), expressed in oocytes by mRNA injection, 
and analyzed by low denaturing SDS-PAGE and western blotting (Fig. 3-4B). 
The dimer to monomer ratio was quantified for four biological repeats (note that 
the asterisks refer to dimers and arrows to monomers); Fig. 3-4C demonstrates 
that the RRMs and ZFs were particularly important for dimer formation. Indeed, 
the RRMs and ZFs are highly structured and surface-exposed, making them 
amenable for protein-protein interactions. Also note that although the 
dimerization status of CPEB is regulated during meiotic progression, alanine 
mutations (CPEB-AA) and phosphomimetic mutations (CPEB-DD) of aurora A 
phosphorylation sites did not affect its dimerization. 
 We further generated various CPEB constructs that would be predicted to 
favor dimer or monomer formation (Fig. 3-4D). For CPEB dimers, the first one 
consisted of a single polypeptide containing two full-length CPEB proteins 
separated by a linker sequence (4 HA epitopes, a total of 40 amino acids, 
depicted by a grey line of CPEB-CPEB in Fig. 3-4D) that should allow for free 
rotation of the CPEB proteins (Erickson, 2009; Robinson and Sauer, 1998) 
(designated as CPEB-CPEB or C-C). The second was CPEB with an N-terminal 
coiled-coil dimerization domain that was modified from the yeast transcriptional 
factor GCN4 (designated as coil-CPEB) (Havranek and Harbury, 2003; Wayne et 
al., 2010). To generate monomeric constructs, full length CPEB was fused with 3 
HA epitopes (a total of 31 amino acids) followed by RRM2 of CPEB. The HA 
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epitopes constitute a flexible linker between full length CPEB and RRM2 so that 
the isolated RRM could interact with the RRM of CPEB, thus forming an 
intramolecular interaction that should preclude an intermolecular interaction 
between two CPEB molecules (Wayne and Bolon, 2007). CPEB-∆RRM was 
identified as a monomer in the domain requirement for dimerization (Fig. 3-4A-C); 
CPEB-6A refers to CPEB with mutated cdk1 phosphorylation sites (Mendez et al., 
2002), which was unexpectedly found to have reduced dimerization potential, 
possibly due to a change in the surface charge thereby altering three-
dimensional conformation. Analyzed by mild denaturing SDS-PAGE, Fig. 3-4E 
demonstrates that indeed the monomeric constructs had lower potential to form 
an intermolecular dimer (marked by asterisks) compared to the monomeric 
species (marked by arrows). In summary, in Fig. 3-4, we show that CPEB 
dimerizes through the RNA-binding region, and based upon this knowledge, 
CPEB dimeric and monomeric mutants are generated for detailed study. 
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Figure 3-4. The CPEB RNA-binding domain is required for dimerization. (A) 
Serial deletions of CPEB used in this study. (B) mRNAs encoding the proteins 
noted (with HA epitopes at the carboxyl ends) in panel A were injected into 
oocytes, which was followed by western blotting analysis. Arrows indicate 
monomers and asterisks indicate dimers. (C) Quantification of the results from 
four experiments similar to those presented in panel B. **: p value < 5 × 10-3; ***: 
p value < 5 × 10-4 as determined by paired t-test comparing to the full-length 
CPEB (FL). CPEB-AA and DD are alanine and phosphomimetic mutations of 
aurora A phosphorylation sites, respectively. (D) Depiction of dimer and 
monomer CPEB constructs. The solid line indicates N terminal half of CPEB; the 
closed circles indicate RRMs and the dashed line indicates ZFs. A curved grey 
line indicates the linker; a coiled-coil structure indicates the dimerization domain 
from GCN4, and small A’s are alanine mutations. Dimeric CPEBs are i) CPEB-
CPEB: tandem CPEB in single peptide, and ii) Coil-CPEB: CPEB fused with 
GCN4 dimerization domain (coiled-coil domain) at the N terminus. Monomeric 
CPEBs are i) CPEB-RRM2: CPEB fused with an additional RRM to introduce 
intramolecular interaction and blocks intermolecular interaction, ii) ∆RRM: 
deletion of the dimerization domain characterized in (A-C), and iii) 6A: 6 point 
mutations of cdk1 phosphorylation sites that may change the surface charge and 
thus the conformation of CPEB to favor monomeric status. (E) Various CPEB 
proteins expressed in oocytes were assayed by mild denaturing SDS-PAGE 
(0.5% SDS with no reducing agent in the sample buffer), which shows that the 
monomeric constructs depicted in (D) indeed possess lower dimerization 
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potential compared to CPEB WT. Arrows indicate monomers and asterisks 
indicate dimers. 
 
 
 
 
 
 
 
 
 
Figure 3-4 
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CPEB dimers do not UV crosslink to RNA 
 CPEB dimerization occurs through the RNA-binding domain, which could 
preclude binding to RNA. To investigate this possibility, UV crosslinking with 
radiolabeled RNA and wild-type (WT) or dimeric CPEB was carried out. Extracts 
from oocytes injected with WT and CPEB-CPEB (Fig. 3-5A, upper panel) or WT 
and coil-CPEB constructs (Fig. 3-5A, lower panel) were primed with radiolabeled 
RNAs that contained or lacked CPEs, which was followed by UV irradiation, 
RNase digestion, and analysis by SDS-PAGE and phosphorimaging. Compared 
to the endogenous CPEB, which clearly crosslinked to CPE-containing RNAs, 
neither the tandem CPEB nor the coiled-coil domain-fused CPEB crosslinked to 
the RNA probes (Fig. 3-5A). Along the same lines, endogenous dimeric CPEB 
also showed no 32P-label transfer in the mild denaturing SDS-PAGE (Fig. 3-5B). 
These results indicate that CPEB dimerization occurs at the expense of RNA 
binding as assessed by UV crosslinking. 
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Figure 3-5. Dimeric CPEBs do not crosslink to RNA. (A) Dimeric form of CPEB, i. 
e. tandem CPEB-CPEB and coiled-coil CPEB, were ectopically expressed in 
oocytes. The endogenous CPEB from the same lysate crosslinked to CPE-
containing 32P-labeled RNA, while the dimeric CPEBs showed virtually no label 
transfer from the RNA. CPE2/1/0: radiolabled RNA containing 2/1/0 CPE(s), 
CPE1 × 2: twice amount of CPE1 RNA that provides the same number of CPEs 
as CPE2 RNA in the crosslinking reaction. (B) Non-treated oocyte lysate was 
crosslinked to the radiolabeled RNA and analyzed on a mild denaturing SDS-
PAGE. Although the dimeric CPEB was obvious on the western blot, no 
corresponding crosslinking signal was detected by autoradiography.  
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Figure 3-5 
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CPEB dimers undergo rapid meiosis-dependent degradation  
The data in Fig. 3-3 suggest that CPEB dimers are degraded during 
oocyte maturation. To investigate this possibility further, a time course of GVBD-
dependent CPEB degradation was performed. In this experiment, mRNAs 
encoding WT CPEB, CPEB-CPEB, coil-CPEB, CPEB-∆RRM, CPEB-RRM2, or 
CPEB-6A were injected into oocytes followed by treatment with progesterone. A 
time course up to 2 hours after GVBD showed that the dimeric CPEB (CPEB-
CPEB and coil-CPEB) degraded faster than endogenous CPEB, while the 
monomeric CPEB (CPEB-∆RRM, CPEB-RRM2 and CPEB-6A) degraded very 
little (Fig. 3-6A). Quantification of the western blot from up to 5 biological repeats 
(lower panel of Fig. 3-6A) demonstrates that almost all dimeric CPEB degraded 
right after GVBD while still more than 50% of monomeric CPEB remained 2 
hours after GVBD. These results indicate that CPEB dimerization is indispensible 
for cell cycle-regulated protein degradation.  
To explore the mechanism of differential degradation between CPEB 
dimers and monomers, their association with the protein destruction machinery 
was examined. CPEB destruction is initiated by multiple cdk1-catalyzed 
phosphorylations (Mendez et al 2002) following the resumption of oocyte 
maturation. Plx1 binds to one of the cdk1 phosphorylation sites in the PEST 
domain of CPEB, which in turn is recognized by ubiquitin E3 ligase β-TrCP, 
which catalyzes ubiquitination and destruction by the proteasome (Setoyama et 
al., 2007). Co-IP experiments show that although dimeric and monomeric CPEBs 
bound cdk1 similarly, the dimeric CPEB had significantly higher affinity for plx1 
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and β-TrCP relative to monomeric CPEB (Fig. 3-6B). This enhanced binding of 
the protein destruction machinery by dimeric CPEB indicates that its 
conformation provides a particularly accessible binding surface for the 
degradation factors, resulting in robust GVBD-dependent degradation. 
To our surprise, dimeric CPEB also bound many polyadenylation factors 
including symplekin, CPSF100 and ePAB more strongly than monomeric CPEB 
(Fig. 3-6B). It may be that the conformation of dimers is preferred for assembling 
the polyadenylation complex even though the dimeric CPEB complex lacks 
mRNA substrates. We propose that the rapid degradation of CPEB dimers during 
maturation releases the polyadenylation factors to efficiently induce 
polyadenylation and translation of CPE-containing mRNAs. 
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Figure 3-6. Dimerization of CPEB facilitates GVBD-regulated protein destruction. 
(A) WT, dimeric form or monomeric form of CPEB were expressed in dormant 
oocytes, which were then induced into GVBD by progesterone. Quantification 
from up to 5 independent experiments is shown in the lower panel. Compared to 
endogenous and WT CPEB, which were downregulated after GVBD, the 
monomeric form of CPEBs, i. e. ∆RRM, CPEB-RRM2 and 6A, were stable along 
the time course. (B) HA-tagged CPEB and FLAG-tagged cdk1, plx1 and β-TrCP 
were co-expressed in oocytes, followed by IP with HA antibodies and western 
blotting. Monomeric CPEBs were deficient of binding to destruction-related 
factors, including E3 ligase β-TrCP and its upstream kinase plx1, which explains 
the deficiency of the regulated destruction. In addition, the dimeric CPEBs bound 
to polyadenylation factors, symplekin, CPSF100 and ePAB, more efficiently. A 
triangle left to the HA(CPEB) blot indicates nonspecific reactivity of HA antibodies. 
Actin served as a negative control for IP. 
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Figure 3-6 
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The deleterious effects of excess CPEB are reduced by dimerization 
 To further investigate the molecular function of the CPEB dimers, mRNAs 
encoding WT CPEB, tandem CPEB dimers (C-C), and CPEB-∆ZF were injected 
into oocytes and incubated overnight (protein expression shown in Fig. 3-7A). 
The next day, mRNAs encoding luciferase fused to the WT cyclin B1 3’ UTR 
(Luc-WT) or 3’ UTR with mutations in CPEs (Luc-mt) were injected; some of the 
oocytes were then treated with progesterone. The time course from three 
biological replicates shows that WT CPEB slowed the rate of maturation while 
the C-C CPEB did not (Fig. 3-7B). Furthermore, the luciferase activity normalized 
to the amount of mRNA determined by qRT-PCR shows a significant decrease of 
CPE-dependent translation upon GVBD when WT CPEB was overexpressed 
(compare non-injected [NI] to WT of the left group in Fig. 3-7C, ** refers to p < 5 
× 10-3). However, the C-C overexpression did not cause any adverse effect on 
translation; luciferase activity in this case was comparable to the noninjected (NI) 
and was significantly higher than the WT CPEB (# refers to p < 0.05 as in Fig. 3-
7C). Unexpectedly, ∆ZF overexpression caused elevated CPE-dependent 
translation, possibly because it absorbed translational repressors in the absence 
of an RNA substrate. In addition, there was little effect of any of the CPEB 
proteins on the Luc-mt translation (Fig. 3-7C, right). These results suggest that 
CPEB dimerization may be a mechanism to protect cells from excess CPEB, 
which can potentially bind to U-rich but non-CPE sequences, ultimately leading to 
deregulated translation. 
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Figure 3-7. CPEB dimerization ameliorates the deteriorating effect of CPEB 
overexpression. (A) Expression of exogenous CPEB WT, dimer CPEB-CPEB 
and ∆ZF mutant. Tubulin served as a loading control. (B) Exogenous CPEB (WT) 
slowed the rate of oocyte maturation while the CPEB dimer (C-C) had no effect. 
(C) Co-expression of luciferase with CPE-containing 3’ UTR shows that 
exogenous WT CPEB decreased its expression upon GVBD but not the dimeric 
CPEB. Luciferase expression with CPEB dimer (C-C) was significantly higher 
than that of CPEB WT (#), similar to non-injected oocytes (NI). On the right panel, 
various CPEB expression did not affect luciferase expression with no CPE in its 3’ 
UTR (Luc-mt). NI-p: non-injected oocytes without progesterone treatment, NI: 
non-injected, WT: wild-type CPEB, C-C: tandem CPEB dimers, ∆ZF: zinc finger 
deletion of CPEB. For the statistics, one mark represents p-value < 0.05; two 
marks represent p-value < 5 × 10-3; three marks represent p-value < 5 × 10-4 as 
determined by paired t-test. 
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Discussion 
 
In this study, we provide evidence that CPEB forms dimers that i) are 
dynamically regulated during oocyte maturation, ii) are mediated by the RRMs, iii) 
do not bind RNA, iv) strongly associate with the protein degradation machinery, 
and v) are necessary for translation and meiotic progression. Based on these 
results, Fig. 3-8 proposes a model for CPEB dimer dynamics and function. CPEB 
proteins are translational repressors that bind to CPE-containing mRNAs and in 
conjunction with Gld2 and PARN, maintain short poly(A) tails. In immature 
oocytes, most of the free CPEB form dimers through interactions with their RNA-
binding domains; hence, this excess CPEB is unable to bind RNAs that do not 
contain bona fide CPEs. When the cells begin to mature, the dimeric CPEB is 
rapidly destroyed due to its preferential association with the kinase plx1 and the 
ubiquitin E3 ligase β-TrCP, which are activated upon GVBD. The destruction of 
the dimers releases their associated factors, including CPSF and ePAB, to 
possibly interact with the RNA-bound CPEB complex to facilitate polyadenylation 
and translation.  
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Figure 3-8. The model of CPEB dimerization: CPEB dimerizes through the RNA-
binding domain. The dimerization prevents excess CPEB from binding to mRNAs, 
which may cause translational deregulation. Moreover, CPEB dimers have higher 
affinity for degradation and some polyadenylation factors, which leads to rapid 
degradation of dimers. Dimer destruction releases the polyadenylation factors for 
translational activation of CPE-containing mRNA (also see the discussion). 
Abbreviations: CPE: cytoplasmic polyadenylation element, HEX: AAUAAA 
hexanucleotide binding site for CPSF, RBD: RNA-binding domain, CPSF: 
cleavage and polyadenylation specific factor, ePAB: embryonic poly(A)-binding 
protein, plx1: polo-like kinase 1, β -TrCP: β -transducin repeat-containing 
protein- F-box protein of ubiquitin E3 ligase complex, GVBD: germinal vesicle 
break down.  
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Figure 3-8 
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Dimerization of RNA-binding proteins 
Like many protein families, RNA-binding proteins have the potential to 
form homo- and/or hetero-dimers, as well as higher complexes. The active form 
of several RNA-binding proteins occurs when they homo-dimerize. For example, 
yeast She2p binds zip-code elements of ASH1 mRNA, directing it from the 
mother cell to the bud-tip of the daughter cell during mitosis. The locally 
translated Ash1p then acts as a repressor of mating-type switching exclusively in 
the daughter cell. Point mutations that abolish She2p dimerization/tetramerization 
inhibit RNA binding and its bud-tip localization, which is due to its deficiency of 
assembly into She3p-containing translocation mRNPs (Muller et al., 2009; 
Niessing et al., 2004). Therefore, the dimerization/tetramerization of She2p is 
essential for its RNA-binding and local translational control.  
AUF1 (AU-rich element RNA-binding protein 1) is an RNA binding protein 
that interacts with 3’ UTR AU-rich elements (AREs) to facilitate RNA destruction 
through deadenylation (Wilusz et al., 2001). This protein also contains two RRMs, 
both involved in RNA-binding. However, unlike CPEB, AUF1 dimerizes through 
an alanine-rich N terminal domain, as determined by a gel filtration assay. When 
the N terminal dimerization region is deleted, the RNA-binding affinity is about 
10-fold lower compared to the WT (DeMaria et al., 1997). Hence, the 
dimerization domain together with RRMs of AUF1 is essential for RNA binding. 
Double stranded RNA (dsRNA)-binding protein DGCR8 (DiGeorge 
syndrome critical region gene 8), the homologue of Pasha, assists the RNase III 
family enzyme Drosha to cleave primary microRNAs (pri-miRNAs) into precursor 
113 
 
miRNAs. A crystal structure of the core DGCR8 suggests that the two tandem 
dsRNA-binding domains (dsRBDs) interact with a C-terminal helix and is 
arranged with pseudo two-fold symmetry so that the two RNA-binding surfaces 
are exposed and point in opposite directions (Sohn et al., 2007). A gel filtration 
assay shows that the DGCR8 dimer further trimerizes using a helix downstream 
to dsRBDs, allowing cooperative RNA binding. In addition, only this trimeric form 
possesses the pri-miRNA processing ability (Faller et al., 2007), suggesting that 
the trimerization domain may be inhibitory or the trimeric structure can promote 
its enzymatic activity. Collectively, these examples demonstrate many RNA-
binding proteins exert their function in the homo-dimeric/multimeric form. 
However, our studies indicate that dimeric CPEB, though active in the 
degradation pathway (Fig. 3-6), is dormant for RNA binding (Fig. 3-5). These 
results, together with the overexpression assay (Fig. 3-7), suggest that 
dimerization is a mechanism to keep the excess of CPEB inactive.  
It may be intuitive to infer that the CPEB dimer should be deficient in RNA 
binding since the RNA-binding domain is masked by the protein-protein 
interaction. However, many examples show that the RNA-binding proteins can 
dimerize through the RNA-binding motifs but still maintain the RNA binding ability. 
First of all, there are usually multiple RNA binding motifs in an RNA-binding 
protein. In eukaryotic proteins, RRMs are often found as multiple copies within a 
protein (44%, 2 to 6 RRMs) and/or together with other RNA-binding domains 
(21%), among which ZFs are the most frequent (Lunde et al., 2007). The domain 
used for RNA binding and that used for dimerization may not overlap (Daher et 
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al., 2001; Hitti et al., 2004; Martel et al., 2010). Secondly, even if the same motif 
is used for both RNA and protein interactions, the different surfaces may be used 
and thus these two functions do not interfere with each other (Jang et al., 2006; 
Sohn et al., 2007; Toba and White, 2008). In the case of CPEB, probably the 
same surface for RNA binding is used for dimerization and hence the RNA-
binding is blocked in the dimeric CPEB. This hypothesis needs to be further 
determined by detailed structural analysis. Unfortunately, CPEB is extremely 
difficult to purify en masse, which is necessary for crystallization and structural 
investigation. 
Overall, dimerization/multimerization is a common mechanism to regulate 
the binding affinity and function of RNA-binding proteins. However, the impact of 
dimerization/multimerization is specific to each RNA-binding protein that needs to 
be determined experimentally. 
 
Multimerization of ApCPEB and dimerization of xCPEB 
It has been reported that ApCPEB has prion-like properties; that is, it 
acquires a distinct conformation that is self-sustaining and epigenetically-
inherited. In yeast, ApCPEB in this prion-like form has been reported to be the 
active form in that it binds mRNA and stimulates translation (Heinrich and 
Lindquist, 2011; Si et al., 2003). In Aplysia sensory neurons, ApCPEB also can 
form self-sustaining multimers with amyloid characters; in addition, the 
multimerization can be induced by the neurotransmitter serotonin and injection of 
antibodies against the aggregate form of ApCPEB blocks long-term facilitation (Si 
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et al., 2010). The N terminal Q-rich sequence of ApCPEB is required (yet not 
sufficient) to form aggregates in neurons, but this Q-stretch is not present in 
xCPEB, although we can not exclude that xCPEB also multimerizes. Hence, the 
biochemistry of ApCPEB multimerization and xCPEB dimerization is completely 
different. In our study, CPEB forms dimers through the C terminal RNA-binding 
domain and dimeric CPEBs are dormant in the RNA binding and the translation 
regulation. However, there are some common characters between ApCPEB 
multimers and xCPEB dimers. That is, either the multimerization or the 
dimerization is regulated by the extracellular stimulation and is critical for the 
cellular function. ApCPEB multimerization can be stimulated by serotonin and 
may contribute to the persistence of long-term facilitation, whereas xCPEB 
dimerization, which protects the cells from overloading CPEBs, is less prominent 
when cells are treated with progesterone and its degradation is indispensable for 
the meiotic cell cycle progression. 
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Materials and Methods 
 
Antibodies 
Antibodies used in this study include: rabbit anti CPEB (Hake and Richter, 
1994), rabbit anti HA (Sigma), mouse anti HA (Covance), mouse anti α-tubulin 
(Sigma-Aldrich), mouse anti symplekin (BD Transduction Laboratories), rabbit 
anti CPSF100 (Takagaki and Manley, 2000; gift of J. Manley, Columbia 
University), rabbit anti PARN (gift of M. Wormington, University of Virginia), rabbit 
anti ePAB (gift of J. Steitz, Yale University), mouse anti actin, rabbit anti maskin 
(Stebbins-Boaz et al., 1999). 
 
In vitro transcription and in vitro translation 
 RNAs used for oocyte injection were generated with mMESSAGE 
mMACHINE® T3/T7 kit (Ambion). RNAs for protein expression were further 
polyadenylated with E. coli poly(A) polymerase (New England Biolabs).   
 Labeled HA-CPEB protein was synthesized from in vitro transcribed 
mRNA using a rabbit reticulocyte lysate (Promega) following the manufacturer’s 
instruction. The reaction was supplemented with 20 μCi methionine, L-[35S] to 
label the newly synthesized protein and was applied directly to the gel. After 
electrophoretic transfer to nitrocellulose membrane, the protein was visualized by 
western blotting or autoradiography. 
 
Immunoprecipitation (IP) 
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50-100 injected oocytes or HEK 293T cells from a 10 cm dish were 
homogenized in IP buffer (150 mM NaCl, 25 mM HEPES-KOH pH 7.5, 10% 
glycerol, 1 mM MgCl2, 2 mM sodium orthovanadate, 2 mM β-glycerophosphate, 1 
mM phenylmethylsulphonylfluoride [PMSF], 1 mM DTT, 2 mM EDTA, 0.5% Triton 
X-100 and protease inhibitor cocktail [Roche]). The clarified lysate was incubated 
with monoclonal anti-HA-agarose (Sigma-Aldrich) or anti-FLAG M2 affinity gel 
(Sigma-Aldrich) for 2 hours to overnight at 4 ºC with 50 μg/ml RNase A (Sigma-
Aldrich). The collected agarose beads or affinity gel were then washed 5 times 
with the IP buffer before boiling in SDS-sample buffer. 
 
Formaldehyde crosslinking and IP 
 HEK 293T cells expressing both CPEB-HA and CPEB-FLAG or CPEB-HA 
only were homogenized in 1 ml IP buffer, incubated with 50 μg/ml RNase A at 
room temperature for 20 min. To avoid nonspecific aggregation, the lysate was 
diluted with PBS to 10 volumes before adding 32 μl 37% formaldehyde (Sigma-
Aldrich) (final 0.12%). The cell lysate was incubated for 15 min at room 
temperature followed by an additional incubation with anti-FLAG M2 affinity gel 
(Sigma-Aldrich) at 4 ºC overnight. The collected beads were washed twice with 
wash buffer (1X PBS, 0.1% SDS, 0.5% sodium deoxycholate and 0.5% NP-40) 
and 3 times with high-salt wash buffer (5X PBS, 0.1% SDS, 0.5% sodium 
deoxycholate and 0.5% NP-40). Proteins were then eluted from the affinity gel 
following incubation with FLAG peptide at 30 ºC for 30 min. The supernatant was 
concentrated with a speed vacuum contractor to decrease the volume for loading. 
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The affinity gel was further boiled with SDS-sample buffer. The eluates from both 
peptide elution and sample buffer boiling were analyzed by standard SDS-PAGE 
and western blotting.  
 
Gel filtration 
 5 ml of gravity packed control or mature oocytes were homogenized in 
equal volume of IP buffer (see above) supplemented with 1% sodium 
deoxycholate. The homogenate was centrifuged at 5K rpm for 20 min in SW 41 
rotor (Beckman Coulter). The middle layer of the clarified lysate was extracted 
with an 18½G needle and centrifuged again at 36k for 30 min. The clear lysate 
was then passed through the glass wool to remove lipids and 0.45 μm PVDF 
membrane to remove large aggregates and cell debris. It was then loaded onto a 
Hiload 16/60 Superdex 200 prep grade column (Amersham Biosciences) 
attached to FPLC. The flow rate was adjusted to 1 ml/min and 1.5 ml fractions 
were collected for western analysis. 
 
UV-crosslinking 
To perform UV crosslinking, a sequence from the Xenopus cyclin B1 3’ 
UTR, or ones that contained mutations in the CPEs (CPE2: 
gggagauguuuuuaaugcgacucuggcguuuuaauaaagcuca; CPE1: 
gggagauguuuuuaaugcgacucuggcgcgacaauaaagcuca; CPE0: 
gggagaugucgacuuagcgacucuggcgcgacaauaaagcuca) were transcribed in vitro 
with 30 μCi UTP [alpha-32P], extracted with acid phenol/chloroform, and 
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precipitated with isopropanol. 1 × 105 cpm of CPE2 probe was used in the 
crosslinking reaction; Based on the composition of U’s, 0.75 × 105 cpm or 1.5 × 
105 cpm of CPE1 probe was used to achieve the same molecules of probes or 
same number of CPEs in the reaction, respectively. Untreated or injected 
oocytes were lysed in IP buffer and then incubated with the RNA probes in gel 
retardation buffer (10 mM HEPES pH 7.6, 2 mM MgCl2, 0.1 mM ZnCl2, 50 mM 
KCl, 10% glycerol and 1 mM DTT) supplemented with 2.5 mg/ml heparin, 50 
μg/ml tRNA, 0.5 mM DTT and 0.6 unit/μl RNaseOUT for 10 min on ice and then 
10 min at room temperature. The protein-RNA mixture (20 μl) was applied per 
well on a NunclonTM ∆ Surface plate (NuncTM) and UV-irradiated with 500 mJ 
(Stratalinker UV Crosslinker, Stratagene) on iced water. Following 100 ng RNase 
A treatment at 37 °C for 30 min, the mixture was then boiled in SDS-sample 
buffer (omit boiling for low denaturing SDS-PAGE), followed by standard western 
blotting and autoradiography. 
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CHAPTER IV 
 
DISCUSSION AND CONCLUSIONS 
 
 
 
This thesis focuses on the biochemical characterization and functional 
regulation of a sequence-specific RNA-binding protein, CPEB, which controls cell 
cycle progression and neuronal plasticity that underlies learning and memory. 
CPEB, though mostly cytoplasmic at steady state, is shown to shuttle in between 
the nucleus and the cytoplasm in Chapter II. The C terminal RRM domain 
mediates this translocation. Immunostaining detects CPEB on chromosomes, 
and it co-immunoprecipitates with CPE-containing pre-mRNAs as well as the 
nuclear polyadenylation machinery. CPEB may participate in nuclear mRNA 
maturation. The nuclear localization of CPEB enhances cytoplasmic CPE-
mediated translation repression, suggesting that the recognition of the CPE in the 
nucleus ensures CPEB binding to CPE-containing mRNA in the cytoplasm and/or 
(a) nuclear factor(s) contribute(s) to translation regulation. Moreover, from the 
exon array screening, Col9A1 mRNA is shown to be alternatively spliced in a 
CPEB-dependent manner. In our experimental settings, no alternative 
polyadenylation has been identified. However, CPE is often geographically 
associated with HEX (Paris and Richter, 1990; Simon et al., 1992; Stebbins-Boaz 
and Richter, 1994 and personal communication with S. Duan, Harvard University 
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Dana Farber Cancer Institute, and C. Mello, University of Massachusetts Medical 
School). Considering that CPEB’s affinity for the U-rich CPE and the U-rich 
nature of 3’ UTR and the intronic sequence close to the 3’ splice site, CPEB 
might participate in the regulation of alternative splicing and alternative 
polyadenylation under proper conditions (see below). 
In the third chapter of my thesis, I describe the dimerization of CPEB and 
characterize its function. Homodimerization of RNA-binding proteins have been 
reported elsewhere; however, loss of RNA-binding ability upon dimerization is not 
common. CPEB dimerizes through the RNA-binding domain, and the dimeric 
CPEB has almost undetectable RNA-binding capacity as determined by UV-
crosslinking to radiolabeled mRNA, indicating that the dimeric CPEB is 
functionally dormant. Similarly, in the dormant oocytes, the free CPEB (not 
associated to complexes) is mostly dimeric, while in the active oocytes that 
resume the meiotic cell cycle, becomes monomeric. It suggests that the 
dimerization and thus the activity of CPEB is controlled in a cell cycle-dependent 
manner. Further, the biological significance of dimeric CPEB is demonstrated by 
its overexpression: Compared to WT CPEB overexpression that slows oocyte 
maturation and decreases CPE-dependent translation activation, CPEB dimer 
overexpression causes no deleterious effects, suggesting that dimerization is an 
important mechanism to control the cellular concentration of active CPEBs. 
Finally, the dimeric CPEBs have a strong affinity for protein degradation factors 
and are rapidly degraded upon oocyte maturation, a stage that requires a low 
CPEB to CPE ratio to release HEX binding site for translation activation. 
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Collectively, the dimerization of CPEB is critical for translation regulation and cell 
cycle progression. 
 
Modularity of CPEB 
It is speculated that there are more than one thousand RNA-binding 
proteins based on the search of well-defined RNA binding domains (for example, 
RRM, KH and dsRBD) in the human genome (Sanchez-Diaz and Penalva, 2006). 
They are largely diverged to cover various sequence affinity and biological 
functions. However, most RNA-binding proteins are built from a few RNA-binding 
modules (Lunde et al., 2007). This large diversity is accommodated by the 
presence of multiple copies of these RNA-binding domains in various structural 
arrangements to expand the functional repertoire of these proteins. CPEB has 
two RRMs and two ZFs, each of which is capable of binding RNA. This raises the 
question of what the role of each RNA-binding domain is and how they work 
together.  
The RRM is the most common and best-characterized RNA-binding 
module. ~0.5-1% of human proteins contain an RRM. The RRM is approximately 
90 amino acids containing a central sequence of 8 conserved residues that are 
mainly aromatic or positively charged. It is composed of one four-stranded 
antiparallel β-sheet and two α-helices with a topology β1α1β2β3α2β4. Most of the 
residues of RRM are hydrophobic except four conserved RNA-binding residues 
located in the central strands of the β-sheet. One RRM can bind 4 to 6 nt 
depending on how much the appendicle structure is involved in binding. The 
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combination of two or more RRMs allows the continuous recognition of a long 
nucleotide sequence (8 to 10 nt), dramatically increasing the specificity (Maris et 
al., 2005). RRMs are also reported to mediate protein-protein interaction. Many 
RRMs can interact through the α-helices to form a larger RNA-binding surface of 
their β-sheets, but it can also interact through the β-sheet, such as Y14-Magoh, 
thus preventing RNA binding (Fribourg et al., 2003). In eukaryotic proteins, 
RRMs are often found as multiple copies within a protein (44%, 2 to 6 RRMs) 
and/or together with other RNA-binding domains (21%), among which ZFs are 
the most frequent (Lunde et al., 2007). However, no structural studies indicate 
how RRMs and ZFs within the same protein influence each other. CPEB has two 
ZFs, one of which is Cys-Cys-Cys-Cys type and the other is Cys-Cys-His-His 
type. ZF is composed with α helices and β sheets, and can read 4 nt of DNA or 
RNA sequence primarily using residues in α helices (Brown, 2005).  
The CPE is composed of about 6-11 nt (U4-6A1-3U1-2), which may take 2 of 
the RNA-binding modules to achieve the specificity. However, CPEB has 4 
potential RNA-binding modules, and their coordination is unclear. From the 
previous biochemical studies, RRM1 and ZFs are essential for RNA-binding; 
RRM2 is less critical, but its deletion still results in only 15% of RNA-binding 
capacity (Hake et al., 1998). In addition, it is shown that RRM1 is the main RNA-
binding module to distinguish RNA substrates between CPEB1 and CPEB3 
(Huang et al., 2006). Overall, it seems that RRM1 is the core RNA-binding motif 
of CPEB, and ZFs are critical auxiliary binding domains. I reason that RRM2 may 
have additional roles other than an auxiliary RNA-binding domain.  
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From the study presented in this thesis, I suggest that the RNA-binding 
domain of CPEB is also involved in protein-protein interactions. In the study of 
CPEB nuclear translocalization (Chapter II), RRMs are shown to mediate this 
process; however, RNA-binding does not seem to be involved. CPEB itself has 
no canonical NLS but two strong NESs; therefore, it is highly likely that CPEB 
associates with a nuclear importing protein through the RRM-mediated protein-
protein interaction and export using its internal NESs. It is intriguing that many 
RRMs are also reported to be involved in nuclear import in an RNA-independent 
manner. It could be the entire, a part, or multiple RRMs that are responsible for 
the import; sometimes RRMs also behave as an NES. Only in some rare studies 
of yeast have the importing carriers been identified; most of the RRM-interacting 
importers are still unknown (Cassola et al., 2010). It may be helpful to study 
CPEB shuttling behavior using more detailed deletions of the RRMs; however, 
the full mechanism will not be unveiled until the interacting importer is identified. 
From a personal communication with R. Mendez (Centre of Genomic Regulation, 
Spain), CPEB nuclear import is highly regulated in various cell types. Based on 
the model described above, it is likely that the availability of the importer, and the 
modification of CPEB RRMs and/or the importer become important control points 
to regulate CPEB nuclear shuttling and its function. Moreover, in Chapter III 
where CPEB dimerization is characterized, RRMs as well as ZFs, though to a 
lesser extent, are important in mediating the intermolecular dimerization. It is 
likely that CPEB dimerizes and associates with an importing factor with the same 
RRM surface, and thus dimerization may interfere with its nuclear translocation. 
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These interactions must be critical considering the fact that RNA-binding 
domains are the most conserved part of the protein and RRM2 is as conserved 
as other part of RNA-binding domain among species and among CPEB family 
members. The usage of one or some of the RNA-binding modules for protein-
protein interactions reflects the idea of functional modularity of RNA-binding 
proteins. 
 
CPEB Regulon 
 CPEB is very abundant in germline cells and undergoes partial destruction 
during oocyte maturation. During embryogenesis, it becomes enriched in the 
nervous system but expresses at low level in many tissues (Theis et al., 2003). 
CPEB controls the translation of maternal mRNA in early development and later 
in somatic cells. It is interesting to learn that in somatic cells, CPEB seems to 
function in stress-related conditions such as neuronal stimulation (Richter, 2007), 
cellular senescence (Burns and Richter, 2008; Groisman et al., 2006), insulin 
stimulation (I. Alexandrov et al., in press) and inflammation (M. Ivshina et al., 
unpublished results). Perhaps CPEB activates as part of the stress response in 
somatic cells. In accordance with the “RNA regulon” model (Keene, 2007), CPEB 
may regulate a group of mRNAs of the stress response pathway. To establish a 
better map of CPEB regulons requires systematic studies to identify CPEB 
substrates, for example, deep sequencing of mRNAs from CPEB RNP IP to 
identify mRNAs in the CPEB complex, HITS-CLIP (High-throughput sequencing 
of RNA isolated by crosslinking immunoprecipitation) to identify mRNAs directly 
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bound by CPEB, and polysome profiling to identify mRNAs whose translation is 
affected in CPEB KO. In addition, the new-generation sequencers capable of 
sequencing through homopolymers enable deep sequencing of poly(A) tails of 
total mRNAs to identify CPEB-regulated polyadenylation events. These deep 
sequencing experiments will also help to define a CPE; the knowledge of CPE 
consensus is gathered from experimental experience so far. An in vivo-defined 
CPE can improve the experimental design and will be helpful for the systematic 
study of CPEB-mediated function. 
Moreover, the localization and dimerization status of CPEB may be altered 
under stress conditions. It is reported that not only CPEB is localized in the stress 
granule but overexpression of CPEB can induce stress granule formation 
(Wilczynska et al., 2005), suggesting that CPEB is involved in rearranging the 
functional mRNA population in response to stress. The nucleus-cytoplasm 
shuttling behavior is also under regulation. It is possible that by modifying CPEB 
nuclear shuttling, stimuli change the potential of CPEB-mediated translation 
repression to activate or deactivate the CPEB regulon. Furthermore, dimeric 
CPEB is inert with respect to translation and the dimerization is under cell cycle 
regulation in the Xenopus oocyte. Thus, manipulating the CPEB dimerization 
status in response to the stimulus can be an efficient way to regulate the CPEB 
regulon. 
 
CPEB and Non-Coding RNAs 
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  Regulatory non-coding RNAs, including miRNAs and long non-coding 
RNAs (lncRNAs), have come to the focus of gene regulation. miRNAs can lead 
to translational repression, target degradation and/or gene silencing through 
binding the complimentary sequence of the target mRNAs (Bartel, 2004). 
lncRNAs have been thought to be “junk” for decades until several recent findings 
point out their involvement in many important cellular functions, such as 
regulating the activity or localization of proteins and serving as organizational 
frameworks of subcellular structures (Wilusz et al., 2009). RNA-binding proteins 
and non-coding RNAs can both have high affinity for the same mRNAs and thus 
interplay in the regulatory pathway. Two very interesting examples are Pumilio 
with miR-221 and miR-222, and Staufen with Alu elements (Kedde et al., 2010; 
Galgano et al., 2008). Pumilio binds to the 3’ UTR of p27 tumor suppressor, and 
its binding relieve the miR-221 and miR-222 binding sites from the intramolecular 
complimentary sequence. As a result, miR-221 and miR-222 get access to the 
p27 3’ UTR and silence the translation, which leads to rapid entry to the cell cycle 
(Kedde et al., 2010). The RNA binding ability of Pumilio is elevated by hormone-
induced phosphorylation and thus the translation repression is regulated 
accordingly. It is therefore noteworthy that Pumilio binding motifs are enriched 
around predicted miRNA binding sites, suggesting a comprehensive regulatory 
network of Pumilio and miRNAs (Galgano et al., 2008). 
 Staufen is a double-stranded RNA-binding protein that targets an mRNA 
for degradation. An Alu element, the most abundant repetitive elements in human 
genomes, imperfectly base pairs to 3’ UTR of ARF1 mRNA to create a Staufen 
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binding site (Gong and Maquat, 2011). Therefore, the abundance of the 
corresponding Alu element and factors that inhibit or enhance base-pairing 
contributes to the degree of modulation in different cell types or developmental 
stages. 
 CPEB co-immunprecipitates with small RNAs (I. Groisman and J. Richter, 
unpublished results), which can result from two scenarios. One is that CPEB 
binds directly to small RNAs and may direct them to, or compete them away, 
from mRNA substrates. The other is that the co-IP’d small RNAs are associated 
with the mRNA pulled down by CPEB. In this case, CPEB may modulate the 
accessibility of small RNA binding sites by occupying a close-by CPE. In either 
way, CPEB is very likely to regulate small RNA binding to the CPE-containing 
mRNAs. Moreover, it needs to be pointed out that not only RNA-binding proteins 
can intervene in the function of miRNAs, but miRNAs can also modulate the 
translation regulation of RNA-binding proteins through base pairing with mRNA 
targets (Eiring et al., 2010). In addition, CPEB4 recognizes a stem-loop structure 
(see Appendices), which features primary- and precursor-miRNA. Therefore, as 
a nuclear-cytoplasmic shuttling protein, CPEB4 may regulate multiple steps of 
the biogenesis of miRNA. So far no effort has been made to identify CPEB 
interaction with lncRNAs. However, lncRNAs are reported to repress translation, 
many through the inhibition of translation initiation in response to the stimulus 
(Hasler and Strub, 2006), so the interplay between CPEB and lncRNA on the 
translational control can be critical for the development and the stress response. 
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Conclusions 
 CPEB is a key regulator of the translational control of many biological 
processes. It reacts to extracellular stimuli to switch on or off various translation 
programs. Hence, the study of the CPEB-mediated translation network is not 
complete without studying the regulation of CPEB itself. Taking advantage of the 
established biochemical techniques of Xenopus oocyte system, this thesis 
research presents evidence of CPEB nuclear translocation and dimerization, the 
biochemical and molecular mechanism underlying these processes and the 
biological relevance of them. 
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Abstract 
 
 CPEB is a sequence-specific RNA binding protein that promotes 
polyadenylation-induced translation in oocytes and neurons. Vertebrates contain 
three additional genes that encode CPEB-like proteins, all of which are 
expressed in the brain. Here, we use SELEX, RNA structure probing, and RNA 
footprinting to show that CPEB and the CPEB-like proteins interact with different 
RNA sequences and thus constitute different classes of RNA binding proteins. In 
transfected neurons, CPEB3 represses the translation of a reporter RNA in 
tethered function assays; in response to NMDA receptor activation, translation is 
stimulated. In contrast to CPEB, CPEB3-mediated translation is unlikely to 
involve cytoplasmic polyadenylation since it requires neither the cis-acting 
AAUAAA nor the trans-acting CPSF, both of which are necessary for CPEB-
induced polyadenylation. One target of CPEB3-mediated translation is GluR2 
mRNA; not only does CPEB3 bind this RNA in vitro and in vivo, but an RNAi 
knockdown of CPEB3 in neurons results in elevated levels of GluR2 protein. 
These results indicate that CPEB3 is a sequence-specific translational regulatory 
protein. 
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Introduction 
 
 One widely used mechanism to activate the translation of dormant mRNAs 
is cytoplasmic polyadenylation. While this process was first described in 
invertebrates, it is also important for vertebrate oocyte development (Hake and 
Richter, 1994; Sheets et al., 1995; Stebbins-Boaz et al., 1996; Tay and Richter, 
2001), cell cycle progression (Groisman et al., 2002), and neuronal synaptic 
plasticity (Alarcon et al., 2004). CPEB is the key protein that controls this process; 
it binds the 3’ UTR cytoplasmic polyadenylation element (CPE; consensus 
UUUUUAU) of target mRNAs (Hake and Richter, 1994). CPEB also interacts with 
a number of proteins that are important for polyadenylation and include i) 
cleavage and polyadenylation specificity factor (CPSF), which binds the 
hexanucleotide AAUAAA, another cis element in the RNA essential for 
polyadenylation, ii) symplekin, a scaffold protein that helps link CPEB to CPSF, 
and iii) Gld-2, a cytoplasmic poly(A) polymerase (Barnard et al., 2004). CPEB 
also binds a guanine nucleotide exchange factor (Reverte et al., 2003), an RNA 
helicase (Minshall and Standart, 2004), and amyloid precursor proteins (Cao et 
al., 2005), all of which influence CPEB-dependent polyadenylation. 
Polyadenylation is initiated when CPEB is phosphorylated by Aurora A, which 
results in an enhanced interaction between CPEB and CPSF and between CPEB 
and Gld-2 (Mendez et al., 2000a, 2000b; Barnard et al., 2004). These events 
induce Gld-2 to extend the poly(A) tail. Translation of CPE-containing RNAs is 
most proximally controlled by Maskin, which simultaneously binds CPEB and the 
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cap-binding factor eIF4E. The association of Maskin with eIF4E inhibits assembly 
of the eIF4F (eIF4E, eIF4G, eIF4A) initiation complex (Stebbins-Boaz et al., 1999; 
Richter and Sonenberg, 2005). Phosphorylation (Barnard et al., 2005) as well as 
polyadenylation and poly(A) binding protein (PABP) help Maskin dissociate from 
eIF4E, thereby allowing translation initiation to proceed (Cao and Richter, 2002; 
Barnard et al., 2005). 
 In neurons, CPEB promotes the dendritic transport (Huang et al., 2003) 
and polyadenylation-induced translation of CPE-containing mRNAs following 
synaptic stimulation (Wu et al., 1998; Huang et al., 2002; Du and Richter, 2005). 
Because local mRNA translation modulates synaptic efficacy (Steward and 
Schuman, 2003; Bailey et al., 2004), it is not surprising that CPEB knockout (KO) 
mice display defects in synaptic plasticity (Alarcon et al., 2004), as do Aplysia 
neurons treated with an antisense oligonucleotide against CPEB mRNA (Si et al., 
2003). However, three additional genes encode CPEB-like proteins in 
vertebrates (Mendez et al., 2001) that, at least at the RNA level, are expressed in 
the brain (Theis et al., 2003; Human Unidentified Genome Encoded (HUGE) 
Large Protein Database). The possibility that these proteins might partially 
compensate for the loss of CPEB caused us to investigate not only their RNA 
binding specificities, but also their involvement in translational control in neurons. 
All CPEB-like proteins in both vertebrates and invertebrates have a similar 
structure in which most of the carboxy terminal region is composed of two RNA 
recognition motifs (RRM) and two zinc fingers. At least for CPEB, all of these 
domains are important for binding to the CPE with high affinity (Hake et al., 1998). 
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In spite of these structural similarities, however, a sequence comparison of the 
RNA binding regions indicated that CPEB is distinct from CPEBs 2, 3, and 4 
(Mendez and Richter, 2002). Indeed, mouse CPEB is more similar to Drosophila 
CPEB (also known as Orb) than it is to mouse CPEBs2-4. This observation 
suggests that CPEB2-4 might bind a sequence other than the CPE. Using the 
RNA binding region of CPEB4, we now report that SELEX (systematic evolution 
of ligands by exponential enrichment) analysis has identified a new binding 
sequence for these proteins. RNA gel shifts using this sequence as well as the 
CPE demonstrate that while CPEB binds the CPE and CPEBs2-4 bind the 
SELEX sequence with high affinity (Kd of 100-160 nM), CPEB does not bind the 
SELEX sequence nor do CPEBs3-4 bind the CPE. While CPEB recognition of 
the CPE does not appear to involve RNA secondary structure, such structure is 
important for CPEB3-4 interaction with the SELEX sequence. CPEBs3-4 are 
expressed in partially overlapping regions in the brain and are found in dendrites; 
CPEB3 co-localizes with a synaptic marker while CPEB4 does not. Experiments 
employing reporter RNAs transfected into neurons demonstrate that CPEB3 
represses and then stimulates translation in response to NMDA treatment. 
CPEB3 neither interacts with CPSF nor requires the AAUAAA hexanucleotide for 
translational activation, implying that, in contrast to CPEB, it regulates translation 
in a polyadenylation-independent manner. The AMPA receptor GluR2 mRNA is a 
target of CPEB3 regulation; not only does CPEB3 bind this RNA in vivo, but an 
RNAi knockdown of CPEB3 in neurons results in elevated translation of GluR2 
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mRNA. Thus, based on RNA binding specificity and functional regulation of 
translation, CPEBs 2-4 form a class of proteins distinct from CPEB. 
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Results 
 
All CPEB-like proteins have a carboxy terminal RNA binding domain 
(RBD), which is comprised of two RRMs and two zinc fingers, and an amino 
terminal domain that in the case of CPEB, stimulates polyadenylation-induced 
translation once it is phosphorylated on T171 (in the mouse protein, S174 in 
Xenopus) by Aurora A. Although there is no significant identity among the amino 
terminal domains of the CPEB proteins within a species (e.g., the mouse) or 
between species (e.g., mouse and fly), there is strong identity among the RNA 
binding domains. For example, mouse CPEB and mouse CPEB2 are 45% 
identical in this region. However, mouse CPEB2, CPEB3, and CPEB4 are >95% 
identical. Interestingly, mouse CPEB has a higher identity to fly CPEB (also 
known as Orb) than it does mouse CPEB2-4. Moreover, fly CPEB2 is more 
similar to mouse CPEB2-4 than it is to fly CPEB (Fig. A-1A). These comparisons 
imply that CPEB2-4 might interact with a different sequence than CPEB. Such a 
possibility was further suggested by experiments in injected Xenopus oocytes. 
While mRNA encoding CPEB or CPEB3 had no effect on progesterone-induced 
oocyte maturation, mRNA encoding a chimeric protein composed of the 
regulatory domain of CPEB3 fused to the RNA binding domain of CPEB inhibited 
maturation (Fig. A-1B left, the right shows western blots of the resulting proteins). 
We infer that the chimeric protein acted as a repressor of translation of CPE-
containing mRNAs required for maturation because it could not respond to 
progesterone stimulation; CPEB3 did not repress translation because it could not 
bind these mRNAs (see below). 
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Figure A-1. Structural features and comparison of CPEB-like proteins. (A) All 
CPEB-like proteins have an amino terminal region and a carboxy region 
containing two RNA recognition motifs (RRM) and two zinc fingers (Zif). CPEB 
T171, which is not conserved in CPEB2-4, must be phosphorylated for 
polyadenylation to occur. Among the amino terminal regions of the CPEB 
proteins, there is little identity (NS, not significant). Among the RNA binding 
domains, there is considerable identity. However, mouse CPEB (designated 
CPEB1 for convenience) is closer to Drosophila CPEB (Orb) than it is to mouse 
CPEB2; in addition, Drosophila CPEB2 (Orb2) is more similar to mouse CPEB2 
than it is to Orb. Mouse CPEBs 2-4 are nearly identical in the RNA binding 
domains. (B) Xenopus oocytes were injected with water or RNA encoding myc-
CPEB or CPEB3, or myc fused with the amino domain of CPEB3 and the RBD of 
CPEB. The oocytes were incubated with progesterone and scored for oocyte 
maturation as assessed by germinal vesicle breakdown (GVBD). A western blot 
probed with myc antibody shows the level of the myc fusion proteins in oocytes. 
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Figure A-1 
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SELEX identifies CPEB2-4 binding sequences 
 To determine whether the RNA binding domains (RBDs) of CPEB2-4 
indeed interact with sequences other than the CPE, a SELEX experiment was 
performed. The RNA binding domain of CPEB4 was mixed with in vitro 
synthesized RNA derived from an oligonucleotide library composed of a 
randomized 25-mer flanked by constant regions for PCR; the mixture was 
subjected to 8 rounds of binding and elution. After the final elution, the RNA was 
cloned and the sequences of 50 plasmid inserts were determined, some of which 
are shown in Fig. A-2A. In vitro gel shifts confirmed that CPEB4 RBD bound all 
cloned RNAs tested (Fig. A-2B). Two point mutations that disrupted the CPEB4 
zinc fingers abrogated binding to a selected RNA, 1904 (Fig. A-2C), indicating 
the importance of this domain for RNA interaction, which is consistent with a 
previous finding that the zinc fingers are important for CPEB to bind the CPE 
(UUUUAU derived from Xenopus mos, de Moor and Richter, 1999; Hake et al., 
1998). Further analysis showed that while CPEB3 and 4 bound the 1904 
sequence, CPEB did not. Moreover, CPEB did bind CPE-containing RNA, as 
expected, but CPEB3 and 4 did not (Fig. A-2D). When analyzed kinetically, the 
binding constant (Kd) of CPEB for the CPE was 130 nM (Hake et al., 1998); 
CPEB did not interact with 1904. In contrast, while the CPEB3 and CPEB4 RBDs 
(>95% identical, Fig. A-1) did not bind the CPE, the Kds for the 1904 sequence 
were 166 nM and 100 nM, respectively. Thus, CPEB and CPEB2-4 have different 
RNA binding specificities. 
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 To identify the origin of these different RNA binding specificities, chimeric 
molecules composed of RRM1, RRM2, and the zinc fingers (Zif) from CPEB and 
CPEB3 were fused to maltose binding protein (MBP) and subjected to RNA gel 
shifts and UV crosslinking analysis with the CPE and the 1904 SELEX sequence 
(Fig. A-2F). Although the entire CPEB RBD was the most efficient at binding the 
CPE, RRM1 was essential for this binding (gel shift and UV crosslink). Similarly, 
the entire CPEB3 RBD was the most efficient at binding the 1904 sequence 
(compare gel shift and UV crosslink), but in this case, both RRMs were important 
for binding. Exchange of the zinc fingers had no effect on RNA binding. Thus, 
while certain domains within CPEB (RRM1) and CPEB3 (RRMs 1 and 2) are 
important for binding specificity, the zinc fingers of both proteins (see also Hake 
et al., 1998), while important for RNA interaction, do not confer specificity. 
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Figure A-2. Analysis of CPEB and CPEB4 interaction with RNA. (A) The CPEB4 
RBD was mixed with RNA synthesized in vitro from oligonucleotides containing a 
randomized 25-mer central domain flanked by constant regions used for 
transcription and PCR. The RNA-protein complexes were collected on filters, 
eluted, and the cycle repeated for 8 rounds before cloning. Representatives of 50 
clones are shown. (B) Several SELEX RNAs were synthesized in vitro with 32P-
UTP and used for gel shifts with 500 nM CPEB4RBD. (C) The CPEB4 RBD, 
containing or lacking the zinc finger (ZF) was used in gel shifts with SELEX 
sequence 1904. (D) RNA gel shifts were performed with CPEB, CPEB3, or 
CPEB4 with CPE-containing RNA or the 1904 sequence. (E) A kinetic analysis of 
CPEB3 and 4 RBD interactions with the 1904 sequence or the CPE was used to 
calculate equilibrium dissociation constants (Kd). Similar experiments were 
performed with CPEB binding to the 1904; the binding of CPEB to the CPE was 
taken from Hake et al. (1998). (F) Various regions of the RBDs of CPEB and 
CPEB3 were fused to maltose binding protein (MBP), expressed in bacteria, and 
used for RNA gel shifts and UV crosslinks with the CPE or the 1904 sequence. 
The bottom panels show that equal amounts of the MBP fusion proteins were 
used on all experiments. 
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Figure A-2 
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CPEB3-4 RBD recognizes RNA secondary structure 
 One of the goals of the SELEX experiments was to identify endogenous 
mRNAs that are bound by the CPEB3-4 RBD. To make a search more specific, 
we delineated the nucleotides necessary for binding. Using 1904 as a substrate, 
mutations in several regions of the 25-mer destroyed or reduced RNA binding 
(Fig. A-3A). Surprisingly, deletion of the 3’ but not 5’ constant region destroyed 
binding; the 25-mer alone was not bound by the RBD (Fig. A-3A). Using the 
mfold program (Zucker, 2003), the 5’ constant region in the deletion RNA M14 is 
predicted to fold into a secondary structure with poly U in the loop; similar 
structures were predicted for most of the other selected RNAs (Fig. A-3B and 
data not shown). To assess whether such a possible structure (∆G of -21.3 
kcal/mol) could be important for CPEB4 binding, three bases were mutated in the 
bottom stem (CAC for GUG), which completely abrogated CPEB4 binding (Fig. 
A-3B). Compensatory changes in the complementary sequence (denoted REV 
for reverse, GUG for CAU) restored binding by CPEB4, however, substitution of 
the GUG for CAU alone did not restore binding. These results suggest that RNA 
secondary structure could be necessary for CPEB4 binding. 
To further assess this hypothesis, 5’ end-labeled RNA was cleaved with 
the single strand specific lead acetate (Darnell et al., 2005), and RNase V1, 
which cleaves double stranded regions (Lockard and Kumar, 1981). These 
samples were resolved on a sequencing gel and compared to parallel lanes 
containing untreated RNA, RNA partially hydrolyzed with NaOH, and RNA 
cleaved with RNase T1 to locate the guanosines (Fig. A-3C). Lane 4 shows that 
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the uridine residues predicted to reside in a loop structure (panel B) were 
susceptible to lead cleavage, which was reduced by inclusion of MgCl2, a 
competitor of the lead ion (lanes 5,6). These uridine regions were also resistant 
to RNase V1 cleavage, further demonstrating that they are not base-paired with 
other residues. To determine the region of the RNA bound by the CPEB4 RBD, 
RNA footprinting was performed. Increasing amounts of CPEB4 RBD was mixed 
with 5’ end-labeled RNA; the RNA was then cleaved by the hydroxyl radical 
generated from a mixture of Fe/EDTA (Wang and Padgett, 1989). Compared to a 
sample digested with hydroxyl radical only (no protein) (lane 4), CPEB4 
protected two regions of the RNA, one was the single stranded uridines together 
with the 5’ proximal stem while the other was an adjacent double stranded region 
(lane 9). The binding of CPEB4 to the 5’ proximal stem is consistent with the 
compensatory mutagenesis result and further suggests the significance of RNA 
structure for CPEB4 binding. Two other SELEX clones gave similar RNA 
footprinting patterns (data not shown). Fig. A-3D depicts a revised secondary 
structure of the minimal RNA required for CPEB4 RBD binding based on the data 
in panels B and C. The residues protected by the CPEB4 RBD are also indicated. 
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Figure A-3. The CPEB4 RBD recognizes RNA secondary structure. (A) 
Nucleotide changes were introduced into the 1904 sequence and the resulting 
RNAs were used for gel shifts with the CPEB4 RBD; the relative amount of 
binding is indicated. (B) Compensatory mutagenesis of M14 RNA. The mfold 
program generated a predicted secondary structure of M14 RNA. The blue line 
denotes the nucleotides derived from the constant sequence, the black box 
indicates the part of the stem used for the mutagenesis, and the red nucleotides 
indicate the mutated sequences. Gel shifts of these RNAs using the CPEB4 RBD 
are shown at right. (C) Structure mapping and RNA footprinting. 5’ end-labeled 
RNA was untreated (lane 1), or subjected to partial alkaline hydrolysis (lane 2), 
digested with RNase T1 (lane 3), subjected to lead acetate cleavage in the 
absence or presence of MgCl2 (lanes 4-6, left panel), or digested with the double 
stranded specific nuclease RNase V1 (lane 7, left panel). For RNA footprinting, 
RNA samples either lacked added protein (lane 4, right), or were 0.25, 0.5, 1, 2, 
or 4 μM CPEB4 RBD and treated with hydroxyl radical (lanes 5-9, right panel). 
The products were then analyzed on a sequencing gel. The protected region is 
denoted by a black bar. (D) Predicted RNA secondary structure and nucleotides 
protected from hydroxyl radical cleavage by CPEB4 RBD; the red box indicates 
the protected nucleotides. 
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Figure A-3 
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CPEB3 and 4 in the brain 
 Western blotting shows that while CPEB3 and 4 are present in many 
tissues including the brain (Fig. A-4A). Immunohistochemistry demonstrates that 
while both proteins were evident in the hippocampus and granule cells of the 
cerebellum, only CPEB4 was detected in Purkinje cells of the cerebellum. In 
contrast, only CPEB3 was detected in mitral cells of the olfactory bulb and 
interneurons of the cerebellum (Fig. A-4B). In hippocampal neurons cultured in 
vitro and stained for Map2 to identify dendrites (not shown), CPEB3 often co-
localized with synaptophysin, a synaptic marker (Fig. A-5A). While CPEB4 
appeared to be adjacent to synaptosphysin immunoreactivity, both proteins were 
strongly detected in the post-synaptic density (PSD) fraction Fig. A-5B). CPEB4, 
the only one tested, co-localized with RNA as assessed by Syto-RNA select 
staining (Fig. A-5A). Finally, both CPEB3 and 4, when fused to GFP, were 
detected in dendrites, often as puncta (Fig. A-5C). Taken together, these data 
show that CPEB3 and 4 are expressed in only partially overlapping regions of the 
brain; within hippocampal neurons, where both are expressed, they appear to be 
synaptic. 
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Figure A-4. CPEB3 and 4 in the brain. (A) Western blots of several mouse 
tissues probed for CPEB3 and 4. The blot also shows that the antibodies for 
CPEB3 and 4 do not cross-react and do not recognize CPEB. The calculated 
molecular sizes of CPEB3 and CPEB4 are ~74 kDa and 78 kDa, respectively. 
However, on SDS gels, their apparent molecular sizes are ~100 kDa and ~98 
kDa, respectively. (B) Immunocytochemistry for CPEB3 and 4 in rat 
hippocampus, cerebellum, and olfactory bulb. The arrows point to specific 
regions of immuno-reactivity in interneurons (IN) and Purkinje cells (PC) of the 
cerebellum and Mitral cells (MC) of the olfactory bulb. 
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Figure A-4 
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Figure A-5. Localization of CPEB3 and 4 in neurons. (A) Co-staining of CPEB3 
or 4 with synaptophysin in 21 day old cultures of hippocampal neurons. CPEB4 is 
also co-stained with the RNA marker Syto-RNAselect after UV crosslinking and 
fixation. (B) Detection of CPEB3 and 4 in the postsynaptic density (PSD) fraction. 
P-CPEB4 refers to putative phosphorylated CPEB4, B refers to the brain extract, 
S refers to the synaptoneurosome fraction, and syn refers to synaptophysin. (C) 
Detection of transfected GFP-CPEB3 and GFP-CPEB4 proteins in dendrites of 
hippocampal neurons co-stained with MAP2. 
  
152 
 
 
Figure A-5 
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CPEB-like proteins and translation 
 To investigate whether the CPEB3 could be involved in translational 
control, we employed a tethered function assay in hippocampal neurons that 
were transfected with several sets of reporter RNAs (Fig. A-6A). They encoded 
the dimeric MS2 coat protein (MS2CP) fused to CPEB3 or mutant CPEB3 
proteins that lacked the amino or carboxy terminal regions, or as a control, 
MS2CP fused to GFP. These RNAs were mixed with RNA encoding firefly 
luciferase that contained or lacked the stem loops recognized by MS2CP. The 
mix also contained RNA encoding Renilla luciferase, which served as an internal 
control. In transfected neurons, MS2CP-CPEB3 and MS2CP-GFP were 
synthesized (Fig. A-6B, left) and gel shifted a probe containing the MS2CP stem-
loops (Fig. A-6B. right). Fig. A-6C shows that relative to MS2CP-GFP, MS2CP-
CPEB3 and MS2CP-CPEB3 amino terminus reduced firefly luciferase expression 
by ~30-40%, which was statistically significant (p<0.01). This reduction was not 
due to a general repression since the substitution of the MS2CP moiety with myc 
had no affect on translation. Moreover, removal of the MS2 stem-loop from firefly 
luciferase abrogated the NMDA-induced translation by MS2CP-CPEB3 (Fig. A-
6D). Thus, CPEB3 can reduce translation when tethered to a specific mRNA. 
 To assess whether CPEB3 can stimulate translation and if so, whether it 
requires AAUAAA, a firefly luciferase containing or lacking this sequence was 
transfected into neurons together with MS2CP-CPEB3 as before and then 
stimulated with NMDA. MS2CP-CPEB3 enhanced translation by 20-30% 
irrespective of whether the AAUAAA was present (Fig. A-6D). The MS2 stem 
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loops were required for MS2CP-CPEB3 translation. This change in translation 
occurred even though the luciferase RNA levels were unchanged (panel E). In 
injected Xenopus oocytes, CPEB was co-immunoprecipitated with CPSF, as 
shown previously (Mendez and Richter 2000b), but CPEB 2-4 were not (panel F). 
Finally, luciferase mRNA was appended with a 3’ UTR containing the 1904 
SELEX sequence and analyzed for translation when co-transfected with myc-
CPEB3 or, as a control, β-galactosidase. CPEB3 reduced translation of the 
reporter RNA by ~25%. While NMDA had no effect on luciferase activity when -
galactosidase was co-transfected, it stimulated luciferase activity by nearly 25% 
when CPEB3 was co-transfected (panel G). These data, as well as those in Fig. 
A-1B, suggest that while CPEB3 repressed and then activated translation in 
response to NMDA, it probably does not do so by changing poly(A) tail length 
because it does not require the cis-acting AAUAAA and does not bind CPSF.  
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Figure A-6. Translational repression in neurons. (A) Hippocampal neurons were 
transfected with mRNAs encoding 1.) Dimeric MS2 coat proteins (MS2CP) fused 
to CPEB3 or amino or carboxy terminal truncations of this protein, or MS2CP 
fused to GFP, and 2.) firefly luciferase whose 3’ UTR contained or lacked the 
MS2 stem-loop, and 3.) Renilla luciferase. (B) Western blot showing the 
expression of the fusion proteins in transfected neurons. The right panel shows 
an RNA gel shift of transfected proteins binding to RNA containing the MS2 
stem-loops. (C) The ratio of firefly/Renilla luciferase activity in neurons 
(normalized to the MS2CP-GFP control) transfected with the RNAs noted in part 
(A) Neurons were transfected with mRNA encoding myc-CPEB3 in place of the 
MS2CP fusions. All the firefly luciferase RNAs contained the MS2 stem-loop in 
the 3’ UTR. (D) Luciferase values calculated as those in part (C) from neurons 
transfected with RNA encoding firefly luciferase that containing or lacking the 
MS2 stem-loop that were treated with NMDA. (E) Semi-quantitative RT-PCR of 
luciferase RNA containing or lacking the MS2 stem loops following RNA 
transfection into neurons; some of the neurons were treated with NMDA. (F) 
Xenopus oocytes were injected with mRNAs encoding fusions between myc and 
CPEB or CPEB2-4. The CPEB proteins were then immunoprecipitated with myc 
antibody and probed for myc, to note level of expression, and the 100 kDa 
subunit of CPSF. G. Hippocampal neurons were transfected with firefly luciferase 
mRNA appended with a 3’ UTR containing the 1904 SELEX sequence, Renilla 
luciferase mRNA, and either myc-CPEB3 or β-galactosidase. Some of the 
neurons were also treated with NMDA. Firefly luciferase, normalized to Renilla 
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luciferase, was then determined. Probability (p) values were derived from the 
Student’s t test. 
 
 
 
 
 
 
 
 
 
 
Figure A-6 
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CPEB3 controls GluR2 mRNA translation 
 Because RNA secondary structure appears to be important for binding by 
CPEB3, BLAST searches for endogenous RNAs based on SELEX sequence 
alone would not be fruitful. Consequently, we considered several neuronal RNAs 
whose translation might be regulated and whose 3’ UTR could contain a stem-
loop structure similar to that shown in Fig. A-3B. The mRNA encoding the AMPA 
receptor GluR2 is dendritically localized and may be subject to translational 
control (Karchimina et al., 2000); the mfold program also predicts several stem-
loop structures that resemble that predicted to form in the 1904 SELEX sequence 
(data not shown). To assess whether CPEB3 might bind this mRNA, the 3’ UTRs 
of GluR2 and Arc (a control) mRNAs were subjected to UV crosslinking in vitro 
with the RBDs of CPEB and CPEB3 fused to MBP. Fig. A-7A shows that the 
RBD of CPEB3, but not of CPEB, strongly crosslinked to the 3’ UTR of GluR2 but 
not of Arc, suggesting that GluR2 RNA could be a direct binding substrate of 
CPEB3. To identify the region of GluR2 3’ UTR bound by CPEB3, a deletion 
series was constructed and used for in vitro crosslinking to CPEB3 RBD (Fig. A-
7B). With the exception of nucleotides 1-474, CPEB3 RBD bound to multiple 
regions throughout the length of the 3’ UTR. Additional deletions were 
constructed that were used for RNA gel shifts (Fig. A-7C). Again, CPEB3 bound 
to multiple regions of the 3’ UTR. The binding to one of the regions that was 
chosen, L4, was specific since the shift was competed away when the 1904 
SELEX sequence was added to the mix but not when 1904-M1 was added. 
Moreover, a 202 base fragment (S4) derived from the L4 RNA was bound by 
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CPEB3, which again was competed by the 1904 sequence but not by the 1904-
M1 sequence (Fig. A-7D).  
The S4 RNA was used for structure mapping as in Fig. A-3. Multiple 
regions were cleaved by lead acetate, including one containing multiple uridine 
residues (Fig. A-7E, lane 4). This region was not cleaved by the double strand 
specific RNase V1 (lane 7). Sequences including these single stranded uridines 
were protected by CPEB3 RBD from cleavage by the hydroxyl radical (Fig. A-7F, 
lanes 4-8). Thus, the CPEB3 RBD may interact with a sequence and structure in 
GluR2 similar to the sequence and structure identified by SELEX. We also note 
that S4 contains a CPE-like sequence, which interacts with CPEB in vitro (data 
not shown). 
To determine whether CPEB3 binds GluR2 mRNA in vivo, living cultures 
of hippocampal neurons were irradiated with UV light, which was followed by cell 
homogenization in detergent-containing buffer to reduce nonspecific adsorption 
followed by immunoprecipitation with CPEB3 antibody or IgG. The precipitates 
were then deproteinized and subjected to RT-PCR for Arc, Map2, neurofilament 
(NF), or GluR2 RNAs. While all the RNAs were clearly amplified from input 
material, only GluR2 RNA was amplified from the CPEB3 co-immunoprecipitate. 
No RNAs were amplified from the control IgG immunoprecipitate (Fig. A-8A). 
Thus, GluR2 mRNA is an in vivo substrate of CPEB3. 
 We next performed RNAi knockdown experiments to examine whether 
CPEB3 regulates GluR2 mRNA translation in neurons. Hippocampal neurons 
cultured four days were infected with lentivirus containing or lacking a short 
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hairpin sequence for CPEB3 under the control of the U6 promoter. After a further 
four days of culture, the cells were harvested and the extracted protein was 
probed on western blots. In two independent experiments, CPEB3 protein was 
reduced by 80-99% (Fig. A-8B). In contrast, GluR2 levels increased by three fold 
while αCaMKII and synaptophysin were unaffected. Because the CPEB3 
knockdown had little effect on the level of GluR2 RNA level (Fig. A-8B), we infer 
that the translation of GluR2 mRNA is under negative regulation by CPEB3. It is 
possible that GluR2 mRNA localization could also be affected. Finally, we note 
that GluR2 levels were identical in wild type and CPEB knockout hippocampus, 
indicating that the expression of GluR2 RNA is controlled by CPEB3 and not 
CPEB. 
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Figure A-7. CPEB3 binds the GluR2 3’ UTR. (A) Maltose binding fusion proteins 
containing the RBD of CPEB or CPEB3 were expressed in bacteria and used for 
in vitro UV crosslinking with 32P-labeled 3’ UTRs of Arc and GluR2 mRNAs. (B) 
Deletions of the GluR2 3’ UTR were used for UV crosslinking with His-tagged 
CPEB3 RBD. (C) Additional deletions of GluR2 3’ UTR were used for RNA gel 
shift reactions with His-tagged CPEB3 RBD. (D) Some of the gel shift mixtures 
also contained unlabeled 1904 or 1904-M1 RNAs as competitors for CPEB3 
RBD binding. (E) Structure mapping of GluR2 3’UTR fragment, S4. 5’ end-
labeled S4 RNA was either untreated (lane 1), subjected to partial alkaline 
hydrolysis (lane 2), RNase T1 digested (lane 3), treated with 100 mM lead 
acetate in the absence or presence of 10 mM or 100 mM MgCl2 (lanes 4-6, left 
panel), or digested with nuclease V1 (lane 7, left panel) and analyzed on a 
sequencing gel. The sequence corresponding to uridine rich region is shown. (F) 
RNA footprinting of S4. 5’ end labeled S4 RNA was cleaved by hydroxyl radical 
in the absence or presence of 0.25, 0.5, 1.0, 2.0, 4.0 μM CPEB3 RBD (lane 4-8). 
Lane1-3 is the same as in panel (E).  
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Figure A-7 
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Figure A-8. CPEB3 controls of GluR2 mRNA translation. (A) Living cultures of 
hippocampal neurons were irradiated with UV light, homogenized, and subjected 
to immuoprecipitation with CPEB3 antibody or IgG in the presence of SDS-
containing buffer. The precipitated RNA was extracted after proteinase K 
digestion and subjected to RT-PCR for Arc, Map2, neurofilament (NF) or GluR2 
mRNAs. (B) Endogenous CPEB3 knockdown by RNAi. Cultured hippocampal 
neurons were infected with a control lentivirus or one expressing a short hairpin 
RNA against CPEB3 under the control of the U6 promoter. Extracts were then 
prepared from the cells and analyzed for levels of CPEB3, GluR2, αCaMKII and 
synaptophysin. From other cultures, the RNA was extracted and analyzed for 
GluR2 mRNA by real-time PCR. The bottom panel shows the level of GluR2 in 
WT and CPEB KO hippocampus. Tubulin served as a loading control. 
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Figure A-8 
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Discussion 
 
 In this study, we demonstrate that in contrast to CPEB, CPEB proteins 2-4 
do not avidly bind the CPE, but instead strongly interact with a U-rich loop within 
a stem-loop structure. While the zinc fingers are necessary for RNA binding, it is 
RRMs 1 and 2 that confer the binding specificity. These results imply that 
CPEB2-4 probably does not functionally substitute for CPEB since they interact 
with RNAs with different binding specificities. There could, however, be RNAs 
that are bound by CPEB and CPEB2-4. CPEB3 represses translation of a 
reporter RNAs in transfected neurons and stimulate translation in response to 
NMDA. While the mechanism of translational control by CPEB3 is not yet known, 
it does not bind CPSF nor does it require an AAUAAA cis element, implying that 
unlike CPEB, it does not promote cytoplasmic polyadenylation. Most importantly, 
CPEB3 interacts with GluR2 mRNA in vivo and a knockdown of CPEB3 in 
neurons stimulates the translation of this mRNA. Thus, CPEB3 is a sequence-
specific translational repressor that governs the synthesis of the AMPA receptor 
GluR2. 
 Unlike CPEB, the CPEB3-4 RBD recognizes a secondary structure and 
interacts with uridines that are single stranded as well as double stranded stems. 
While the zinc fingers of the RBD are necessary for stable RNA binding, they do 
not confer binding specificity. In other proteins, zinc finger domains have been 
shown to bind double stranded RNA (Yang et al., 1999; Mendez-Vidala et al., 
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2002), and we would hypothesize that this could also be the case with the CPEB 
2-4 RBD. 
 CPEBs 2-4 are functionally distinct from CPEB and may also be distinct 
from one another. While they bind the same cis element, the fact that CPEB3 
and 4 reside in only partially overlapping regions (i.e., both are in the 
hippocampus but only CPEB4 is in Purkinje cells of the cerebellum and only 
CPEB3 is in mitral cells of the olfactory bulb) indicates that they may interact with 
at least some unique RNAs in vivo. In addition, the large amino terminal regions 
of CPEB2-4 proteins are only 33-43% identical. This relatively low identity 
suggests that these proteins could respond to different signaling pathways and/or 
interact with different sets of proteins to modify their activities such as translation 
repression, stimulation, or RNA transport. 
 
Translational control of GluR2 mRNA 
 The use of SELEX to identify CPEB2-4 binding sites in RNA was not 
particularly useful for recognizing endogenous RNA targets since secondary 
structure was important for RNA-protein interactions. Consequently, we 
examined a number of neuronal mRNAs that might form similar secondary 
structures as determined by the mfold program; the mRNA encoding the AMPA 
receptor GluR2 was able to do so and was immunoprecipitated with CPEB3 
following UV irradiation of living neurons. An RNAi knockdown of CPEB3 
stimulated GluR2 levels while having little effect on GluR2 mRNA, suggesting 
that CPEB3 is a specific translational repressor protein. We do note the caveat 
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that our attempts examine the translation of a reporter RNA appended with the 
GluR2 3’ UTR in transfected hippocampal neurons was variable (data not shown), 
perhaps because the RNA was not properly localized or because it exceeded the 
amount of the endogenous CPEB3. Nonetheless, the cumulative data in this 
report do indicate that CPEB3 is at least one factor that mediates GluR2 mRNA 
expression. 
The molecular mechanism by which CPEB3 modulates translation is 
unknown; perhaps it interacts with an eIF4E-binding protein such as Maskin, 
competes with eIF4E for binding to the cap (Cho et al., 2005), or modulates 
ribosomal subunit joining (Ostareck et al., 2001). Irrespective of how CPEB3 
controls translation, the observation that GluR2 is an endogenous target has 
important implications for AMPA receptor regulation. For example, GluR1 mRNA 
is present in dendrites (Miyashiro et al., 1994) and is regulated at least in part at 
the translational level (Kacharmina et al., 2000; Ju et al., 2004). AMPA receptors 
are also controlled at the protein localization level since they are trafficked to the 
membrane in response to activity (Malinow and Malenka, 2002). Thus, both cell 
soma and local synthesis of GluR1 and GluR2 could contribute to the formation 
of functional AMPA receptors 
 
Translational control and synaptic plasticity 
 Intense interest has focused on local (dendritic) mRNA translation since it 
was shown nearly a decade ago to be important for maintaining long-term 
changes in synaptic strength (Kang and Schuman, 1996). Although many studies 
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have confirmed and extended these results (reviewed in Klann and Dever, 2004; 
Sutton and Schuman, 2005), in some ways local translation remains enigmatic. 
For example, while it has become almost axiomatic that activity-induced 
synthesis of new proteins helps distinguish experienced from naïve synapses 
(Steward and Schuman, 2001), a demonstration that specific proteins involved 
has not emerged. The synthesis of several proteins increases upon synaptic 
stimulation, but only ~2-4 fold (e.g., Schratt et al., 2004; Kelleher et al., 2003). 
Such increases could certainly be physiologically significant, especially if they are 
concentrated at particular synapses. Moreover, relatively modest changes in 
many proteins could be essential for plasticity. Alternatively, perhaps the 
synthesis of less abundant proteins, while substantially stimulated by synaptic 
activity, is obscured by the general but low-level increase. Such a possibility is 
particularly intriguing since it is known to occur in other cells. In Xenopus oocytes, 
progesterone stimulation of M-phase progression is accompanied by a ~2-fold 
increase in general protein synthesis. In contrast, proteins such as Mos and 
cyclin B1, which are necessary for M-phase progression, increase from nearly 
undetectable levels to easily observed amounts when assayed by, for example, 
western blots. However, because these proteins are relatively rare compared to 
the bulk of the newly made proteins, they are not readily detected by metabolic 
labeling unless they are specifically immunoprecipitated. Thus, critically important 
proteins could be synthesized at synapses, but because they are not abundant, 
they are difficult to detect. In contrast to specific protein synthesis, the productive 
capture of certain newly made proteins by stimulated synapses may be 
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responsible for regulating synaptic efficacy (Frey and Morris, 1997; Kelleher et al., 
2004).  
While one way to investigate the relationship between protein synthesis 
and plasticity is obviously to identify mRNAs that are translated in response to 
activity, an alternative approach is to first identify translational control proteins in 
the brain and then determine which mRNAs are bound and/or regulated by them. 
For example, a number of CPE-containing RNAs have now been identified that 
undergo activity-dependent polyadenylation (Du and Richter, 2005; Wu et al., 
1998; Shih et al., 2004), presumably because they are bound by CPEB. In this 
study, we have shown that CPEB3 and CPEB4 are components of the 
postsynaptic density and have identified one mRNA that is bound by and under 
the translation control of CPEB3. By defining the precise binding site in GluR2 
mRNA, we may be able to deduce additional RNAs that are regulated by this and 
the other CPEB-like proteins. 
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Materials and methods 
 
Plasmids and protein expression 
E. coli strain BL21(DE3)pLysS (Novagen) was transformed with 
expression plasmids (pET28a) encoding CPEB and the RBDs of CPEB3-4. The 
cells were cultured to OD600 0.3-0.6 before the addition of 1mM IPTG for 30 mins. 
His-tagged proteins were purified using Ni-NTA agarose resin (QIAGEN) and 
dialyzed against 1XGR buffer (10 mM Hepes, pH7.6, 50 mM KCl, 1mM MgCl2, 
0.1mM ZnCl2, 10% glycerol, 1mM DTT) for 2 hours. His-CPEB was denatured 
with 6M urea and then renatured by stepwise lowering of the urea concentration 
in the wash buffer to 2 M urea before elution and dialysis against 1XGR with 2 M 
urea. The CPEB4RBD used for SELEX was further purified by FPLC (AKTA, 
Amersham Pharmacia Biotech) in a HiLoad 16/60 Superdex 200 column in 
1XGR buffer; protein concentrations were determined by BCA protein assay 
reagent (Pierce). 
For other experiments, DH5α cells transformed with plasmids encoding 
MBP fused to CPEB proteins were grown to O.D.600~ 0.6 and then induced with 1 
mM IPTG for 3 hours. The bacterial pellet was resuspended in buffer A (20 mM 
Hepes pH 7.6, 500 mM NaCl, 1 mM MgCl2, 0.5 mM DTT, 0.1% Triton X-100, 
10% glycerol, 1 mM PMSF) and incubated for 30-40 min. on ice with lysozyme (1 
mg/ml). The cells were sonicated to loss of viscosity and clarified by 
centrifugation at 12,000 xg for 15 min. The resulting supernatant was incubated 
with amylose resin (NEB) and washed with 100X volume of buffer A. The protein 
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was eluted with buffer A (100 mM NaCl, no Triton X-100) with 10 mM maltose. 
Gel shift assays typically employed 100 ng of fusion protein. 
 
SELEX 
For SELEX, three oligonucleotide primers were synthesized: PO-67, 
GGGAGAATTCCGACCAGAAGN25TATGTGCGTCTACATGGATCCTCA; PO-69, 
TGAGGATCCATGTAGACGCA; PO-71, 
TAATACGACTCACTATAGGTGGGAGAATTCCGACCAGAAG. To generate 
templates for a SELEX library, these three primers were used in a PCR reaction 
at a ratio of PO-67:PO-69:PO-71=1:1:3. The PCR products were then used for in 
vitro transcription with T7 RNA polymerase. Free nucleotides from the in vitro 
transcription reaction were removed by FPLC using HiPrep 26/10 desalting 
column before further purification by denaturing TBE PAGE. For the SELEX, 
FPLC purified CPEB4RBD was mixed with heat denatured RNA library in 1 ml of 
1XGR buffer containing 160 μg tRNA and 5 mg heparin. RNA-protein mixtures 
were kept on ice for 10 min and at RT for 10 min before being filtered through 
nitrocellulose membranes on a porous plate by gentle suction. The membranes 
were washed with 5ml 1XGR with tRNA (0.5 mg/ml). The membranes were cut 
into small pieces and mixed with Trizol for RNA extraction as described 
(Invitrogen). The extracted RNA was used for reverse transcription to generate 
cDNA by Superscript Reverse Transcriptase II (Invitrogen) and PCR amplification 
using PO-69 and PO-71. The amplified PCR products were used for transcribing 
RNA for next round of SELEX. To increase the binding specificity of selected 
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RNA to CPEB4RBD, the amount of this protein used in each cycle was reduced 
by half from 2 μM for the first cycle to 25 nM for the 7th and 8th cycles. The 
amount of purified RNA library used for each SELEX cycle was 20 μg except the 
first cycle, which was 60 μg. 
 
Electrophoresis mobility shift assay 
RNA probes used for mobility shift assays were labeled by in vitro 
transcription with UTP-[α-P32]. Mutants of 1904 RNA were transcribed from PCR 
products using oligo-nucleotides with the T7 promoter sequence alterations at 
specific sites. For gel shifts, 20 μl reactions in 1XGR buffer included probe RNA 
(various concentrations, ~105 cpm), protein (e.g., CPEB4 RBD), 1 μg tRNA, 50 
μg heparin, and 12 U RNasin. It was kept on ice for 10 mins and then at RT for 
10 mins, before being resolved by TBE-PAGE. 
 
Immunohistochemistry and RNA transfection in neurons 
The two-month-old male mice were anesthetized and perfused with 4% 
formalydehyde. The fixed brains were embedded in paraffin, sectioned at 10 μm 
thickness, and treated with antigen retrieval procedure (Tay et al., 2001) prior to 
incubation with the affinity-purified CPEB3 and CPEB4 antibodies. Hippocampal 
neurons were cultured and immunostained as describe (Huang et al., 2002). 
Other neuronal cultures were UV irradiated in a Stratagene 1800 Crosslinker, 
fixed, and stained with Syto-RNAselect (Molecular Probes). 
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Hippocampal neurons cultured for 9-10 days in Neurobasal medium with 
B27 supplement (Invitrogen) at a cell density of 30,000-40,000/cm2 were co-
transfected (TransMessenger Transfection reagent, Qiagen) for three hours with 
~12 pmol of Ms2CP-CPEB RNA, 1.7 pmol of firefly luciferase RNA appended 
with various 3’ UTRs, and 1 pmol of Renilla luciferase RNA. The transfected 
neurons were stimulated with 50 μM NMDA for three hours before lysis in 100 μl 
of buffer for dual luciferase assay (Promega). To quantify the amount of firefly 
and Renilla luciferase RNAs, total RNA was extracted from transfected neurons, 
reverse transcribed, and subjected to real-time PCR amplification (Huang et al., 
2003). The specific primers used were: firefly sense, 5'-
GAGATGTATTACGCAAAGTAC and antisense 5'-
CCAGTATGACCTTTATTGAGC; Renilla sense, 5'-
GTTGTGTTCAAGCAGCCTGG and antisense 5'-CCAGTGAGTAAAGGTGACAG. 
 
Lentivirus infection of cultured neurons 
To knock down rat CPEB3 (rCPEB3), the coding region of rCPEB3 was 
RT-PCR amplified from total RNA isolated from rat hippocampal neurons and 
cloned to pcDNA3.1+ plasmid. Five shRNA sequences designed against the 
mRNA were cloned into the lentiviral vector PLL3.7-Syn (gift of M. Sheng); one 
that was particularly efficacious when tested in transfected 293T-17 cells 
corresponded to nucleotides 2320-2337 (CCGTACGTGCTGGATGAT) of 
rCPEB3. This particular construct was used to produce lentivirus using the 
viralpower packaging system (Invitrogen) according to the manufacturer’s 
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protocol. Generally, hippocampal neurons (4 DIV) were infected with the virus (1-
2 MOI) for 24 hrs. The infected neurons were cultured for another 3-4 days prior 
to RNA isolation or protein extraction. 
 
Oocyte injection and immunoprecipitation 
Twenty-five ng RNA encoding myc-tagged CPEB, CPEB3 or chimeric 
CPEB was injected to Xenopus oocytes that were cultured for 14 hrs before 
stimulation with progesterone. For immunoprecipitation, 40 injected oocytes were 
homogenized in 200 μl of IP buffer (20 mM Hepes, pH7.6, 150 mM NaCl, 1 mM 
MgCl2, 0.5 mM DTT, 0.1% Triton X-100, 100 μg/ml RNase A) and centrifuged at 
12K xg for 5 min at 4 oC. The supernatant was incubated with myc antibody for 1 
hr and then immunoprecipitated with Dynabeads conjugated with antibody raised 
against mouse IgG. After several washes, the co-immunoprecipitated proteins 
were eluted and analyzed on western blots. For UV-crosslinking and 
immunoprecipitation, 3 plates of hippocampal neurons (~6-7 million cells, 21 DIV) 
were each covered with 200 μl of IP buffer and UV-irradiated on ice for 30 
minutes. The cells were collected and centrifuged at 1000 xg for 5 min. to 
remove nuclei. One twentieth of resulting supernatant was saved for total RNA 
isolation. The remaining solution was equally divided for IgG and CPEB3 
antibody immunoprecipitation using Dynabeads conjugated with antibody against 
rabbit IgG. After 2 hr incubation, the beads were washed 4X with RIPA buffer and 
1X with genomic DNA lysis buffer (50 mM Tris, pH7.4, 10 mM EDTA, 500 mM 
NaCl, 2.5 mM DTT, 0.5mM spermidine, 1% Triton X-100). Approximately 300 μl 
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of proteinase K solution (1 mg/ml in genomic DNA lysis buffer and 0.4 U/μl 
RNase inhibitor) was added to the total lysate and beads and incubated at 37C 
for 30 minutes. The digested mixtures were used for RNA isolation and 
subsequent RT-PCR. The primer sequences are Map2 sense: 5’-
GACAATTGGGTACCTTGCAAC and antisense: 5’-GGAGAAGGCCAGCTGTAG, 
NF sense: 5’-GAGATGTATTACGCAAAGTACC and antisense: 5’-
CCAGTATGACCTTTATTGAGC, GluR2 sense: 5’-
CAGAGCTCAGTCTTAGGCAG and antisense: 5’-
GTTTGTCTCCTTGGAGTACG. 
 
RNA structure probing and footprinting 
 Methods for RNA alkaline hydrolysis, RNase T1 digestion, and lead 
acetate mediated RNA cleavage have been described (Darnell et al. 2005). 5’ 
end-labeled RNA was suspended in HEPES-SBB buffer (25 mM HEPES pH7.6, 
200 mM KOAc, 5 mM Mg(OAc)2), heat denatured and cooled on ice, and 
digested in the presence of 20 μg tRNA with 0.035 unit RNase V1 at 37oC for 5 
mins. The methods for RNA footprinting have been described (Hartmuth et al., 
1999; Lee et al., 2003). The entire rat GluR2 3’UTR can be found in accession 
number NM_017261. 
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